Table of Contents
falseQ30001841873--12-31 0001841873 2023-01-01 2023-09-30 0001841873 2022-01-01 2022-09-30 0001841873 2023-09-30 0001841873 2022-12-31 0001841873 2023-07-01 2023-09-30 0001841873 2022-07-01 2022-09-30 0001841873 2023-01-01 2023-03-31 0001841873 2023-04-01 2023-06-30 0001841873 2022-01-01 2022-03-31 0001841873 2022-04-01 2022-06-30 0001841873 2021-03-08 0001841873 2021-09-30 2021-09-30 0001841873 2022-09-30 0001841873 2023-08-18 2023-08-18 0001841873 2021-12-31 0001841873 2023-03-31 0001841873 2023-06-30 0001841873 2022-03-31 0001841873 2022-06-30 0001841873 us-gaap:CommonClassAMember 2023-09-30 0001841873 us-gaap:CommonClassBMember 2023-09-30 0001841873 us-gaap:OverAllotmentOptionMember 2023-09-30 0001841873 kvsa:AssetHeldInTrustAccountMember 2023-09-30 0001841873 kvsa:ClassBFounderSharesMember 2023-09-30 0001841873 kvsa:ClassKFounderSharesMember 2023-09-30 0001841873 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-09-30 0001841873 us-gaap:CommonClassAMember kvsa:ForwardPurchaseAgreementMember 2023-09-30 0001841873 kvsa:TargetCompanyMember 2023-09-30 0001841873 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2023-09-30 0001841873 kvsa:MarketableSecuritiesHeldInTrustAccountMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001841873 kvsa:MarketableSecuritiesHeldInTrustAccountMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001841873 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember kvsa:ClassKFounderSharesLiabilityMember 2023-09-30 0001841873 kvsa:ClassKFounderSharesLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001841873 us-gaap:DomesticCountryMember 2023-09-30 0001841873 kvsa:SponserMember 2023-09-30 0001841873 kvsa:OperatingCostsIncurredRelatedPartyMember us-gaap:RelatedPartyMember 2023-09-30 0001841873 kvsa:PiperSandlerCoMember 2023-09-30 0001841873 us-gaap:FairValueInputsLevel3Member kvsa:ClassKFounderSharesLiabilityMember 2023-09-30 0001841873 us-gaap:CommonClassAMember 2022-12-31 0001841873 us-gaap:CommonClassBMember 2022-12-31 0001841873 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember kvsa:MarketableSecuritiesHeldInTrustAccountMember 2022-12-31 0001841873 kvsa:MarketableSecuritiesHeldInTrustAccountMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841873 kvsa:ClassKFounderSharesLiabilityMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001841873 kvsa:ClassKFounderSharesLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001841873 kvsa:ClassKFounderSharesLiabilityMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001841873 kvsa:ClassKFounderSharesLiabilityMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001841873 kvsa:ClassKFounderSharesLiabilityMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001841873 us-gaap:MeasurementInputPriceVolatilityMember kvsa:ClassKFounderSharesLiabilityMember 2022-12-31 0001841873 kvsa:ClassKFounderSharesLiabilityMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001841873 us-gaap:DomesticCountryMember 2022-12-31 0001841873 kvsa:OperatingCostsIncurredRelatedPartyMember us-gaap:RelatedPartyMember 2022-12-31 0001841873 us-gaap:FairValueInputsLevel3Member kvsa:ClassKFounderSharesLiabilityMember 2022-12-31 0001841873 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001841873 us-gaap:CommonClassAMember kvsa:CommonStockSubjectToPossibleRedemptionMember 2022-01-01 2022-09-30 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001841873 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001841873 us-gaap:FairValueInputsLevel12And3Member 2022-01-01 2022-09-30 0001841873 us-gaap:CommonClassAMember kvsa:NonRedeemableCommonStockMember 2022-01-01 2022-09-30 0001841873 us-gaap:CommonClassBMember kvsa:NonRedeemableCommonStockMember 2022-01-01 2022-09-30 0001841873 kvsa:TemporaryEquityMember us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001841873 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001841873 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001841873 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001841873 us-gaap:CommonClassAMember kvsa:CommonStockSubjectToPossibleRedemptionMember 2022-07-01 2022-09-30 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001841873 us-gaap:FairValueInputsLevel12And3Member 2022-07-01 2022-09-30 0001841873 us-gaap:CommonClassAMember kvsa:NonRedeemableCommonStockMember 2022-07-01 2022-09-30 0001841873 us-gaap:CommonClassBMember kvsa:NonRedeemableCommonStockMember 2022-07-01 2022-09-30 0001841873 kvsa:TriggeringEventsStockTradingPriceOneMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001841873 kvsa:TriggeringEventsStockTradingPriceTwoMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001841873 kvsa:TriggeringEventsStockTradingPriceThreeMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001841873 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001841873 kvsa:ForwardPurchaseAgreementMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001841873 kvsa:PublicStockholdersMember 2023-01-01 2023-09-30 0001841873 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001841873 us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001841873 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001841873 kvsa:CommonStockSubjectToPossibleRedemptionMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001841873 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001841873 us-gaap:FairValueInputsLevel12And3Member 2023-01-01 2023-09-30 0001841873 srt:MaximumMember 2023-01-01 2023-09-30 0001841873 us-gaap:CommonClassAMember kvsa:NonRedeemableCommonStockMember 2023-01-01 2023-09-30 0001841873 us-gaap:CommonClassBMember kvsa:NonRedeemableCommonStockMember 2023-01-01 2023-09-30 0001841873 kvsa:TemporaryEquityMember us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001841873 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001841873 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001841873 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001841873 us-gaap:CommonClassAMember kvsa:CommonStockSubjectToPossibleRedemptionMember 2023-07-01 2023-09-30 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001841873 us-gaap:FairValueInputsLevel12And3Member 2023-07-01 2023-09-30 0001841873 us-gaap:CommonClassAMember kvsa:NonRedeemableCommonStockMember 2023-07-01 2023-09-30 0001841873 us-gaap:CommonClassBMember kvsa:NonRedeemableCommonStockMember 2023-07-01 2023-09-30 0001841873 kvsa:TemporaryEquityMember us-gaap:CommonClassAMember 2023-04-01 2023-06-30 0001841873 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001841873 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001841873 kvsa:TemporaryEquityMember us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001841873 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001841873 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001841873 kvsa:TemporaryEquityMember us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001841873 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001841873 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001841873 kvsa:TemporaryEquityMember us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001841873 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001841873 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001841873 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-03-08 2021-03-08 0001841873 us-gaap:IPOMember kvsa:SponsorMember 2021-03-08 2021-03-08 0001841873 us-gaap:IPOMember 2021-03-08 2021-03-08 0001841873 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2021-03-08 2021-03-08 0001841873 kvsa:IpoIncludingOverAllotmentOptionMember 2021-03-08 2021-03-08 0001841873 us-gaap:OverAllotmentOptionMember 2021-03-08 0001841873 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-03-08 0001841873 us-gaap:PrivatePlacementMember us-gaap:CommonClassAMember 2021-03-08 0001841873 us-gaap:IPOMember 2021-03-08 0001841873 us-gaap:CommonClassAMember 2023-06-12 2023-06-12 0001841873 us-gaap:CommonClassAMember 2023-06-12 0001841873 kvsa:SponserMember 2022-09-30 0001841873 kvsa:FounderSharesMember 2021-01-19 2021-01-19 0001841873 us-gaap:CommonClassBMember 2021-01-19 2021-01-19 0001841873 kvsa:CommonClassKMember 2021-01-19 2021-01-19 0001841873 kvsa:ClassBFounderSharesMember 2021-02-28 2021-02-28 0001841873 kvsa:PiperSandlerCoMember 2022-09-21 0001841873 us-gaap:CommonClassAMember 2023-11-14 0001841873 us-gaap:CommonClassBMember 2023-11-14 0001841873 kvsa:CommonClassKMember 2023-11-14 0001841873 us-gaap:CommonClassAMember kvsa:TemporaryEquityMember 2022-09-30 0001841873 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-09-30 0001841873 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001841873 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001841873 us-gaap:RetainedEarningsMember 2022-09-30 0001841873 us-gaap:CommonClassAMember kvsa:TemporaryEquityMember 2023-09-30 0001841873 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-09-30 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-09-30 0001841873 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001841873 us-gaap:RetainedEarningsMember 2023-09-30 0001841873 us-gaap:CommonClassAMember kvsa:TemporaryEquityMember 2023-06-30 0001841873 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-06-30 0001841873 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001841873 us-gaap:RetainedEarningsMember 2023-06-30 0001841873 us-gaap:CommonClassAMember kvsa:TemporaryEquityMember 2022-12-31 0001841873 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-12-31 0001841873 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001841873 us-gaap:RetainedEarningsMember 2022-12-31 0001841873 us-gaap:CommonClassAMember kvsa:TemporaryEquityMember 2023-03-31 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-03-31 0001841873 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001841873 us-gaap:RetainedEarningsMember 2023-03-31 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-03-31 0001841873 us-gaap:CommonClassAMember kvsa:TemporaryEquityMember 2022-06-30 0001841873 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001841873 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001841873 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001841873 us-gaap:RetainedEarningsMember 2022-06-30 0001841873 us-gaap:CommonClassAMember kvsa:TemporaryEquityMember 2021-12-31 0001841873 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001841873 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001841873 us-gaap:RetainedEarningsMember 2021-12-31 0001841873 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-03-31 0001841873 us-gaap:CommonClassAMember kvsa:TemporaryEquityMember 2022-03-31 0001841873 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001841873 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001841873 us-gaap:RetainedEarningsMember 2022-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Month iso4217:USD xbrli:shares utr:Year utr:Y
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
 
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
        
    
    
to
    
        
    
    
 
 
Khosla Ventures Acquisition Co.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
  
001-40131
  
85-1488707
(State or other jurisdiction
of incorporation)
  
(Commission
File Number)
  
(I.R.S. Employer
Identification No.)
 
2128 Sand Hill Road
Menlo Park, California
  
94025
(Address of principal executive offices)
  
(Zip Code)
(650)
376-8500
(Registrant’s telephone number, including area code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange
on which registered
Class A common stock, par value $0.0001 per share
  
KVSA
  
The NASDAQ Stock Market LLC
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
Non-accelerated filer   ☒    Smaller reporting company   ☒
Emerging growth company   ☒     
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☒    No  ☐
As of November 14, 2023, 1,919,456 shares of Class A common stock, par value $0.0001 per share, 5,000,000 shares of Class B common stock, par value $0.0001 per share, and 5,000,000 shares of Class K common stock, par value $0.0001 per share were issued and outstanding, respectively.
 
 
 

Table of Contents

KHOSLA VENTURES ACQUISITION CO.

Quarterly Report on Form 10-Q

Table of Contents

 

PART I. FINANCIAL INFORMATION

      1  

Item 1. Financial Statements

      1  

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

      18  

Item 3. Quantitative and Qualitative Disclosures About Market Risk

      21  

Item 4. Controls and Procedures

      21  

PART II-OTHER INFORMATION

      23  

Item 1. Legal Proceedings

      23  

Item 1A. Risk Factors

      23  

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

      23  

Item 3. Defaults Upon Senior Securities

      23  

Item 4. Mine Safety Disclosures

      23  

Item 5. Other Information

      23  

Item 6. Exhibits

      24  

SIGNATURES

      25  

 

Table of Contents
0http://fasb.org/us-gaap/2023#RelatedPartyMemberhttp://fasb.org/us-gaap/2023#RelatedPartyMemberhttp://fasb.org/us-gaap/2023#RelatedPartyMemberhttp://fasb.org/us-gaap/2023#RelatedPartyMember
PART I. FINANCIAL INFORMATION
 
Item 1.
Financial Statements
KHOSLA VENTURES ACQUISITION CO.
CONDENSED BALANCE SHEETS
 
    
SEPTEMBER 30,
2023
(Unaudited)
    
DECEMBER 31,
2022
  
ASSETS
     
Current assets:
     
Cash
    $ 250,000     $ —  
Restricted cash
      1,664,188       —    
Prepaid expenses
      141,764       113,285  
  
 
 
    
 
 
  
Total current assets
      2,055,952       113,285  
Marketable securities held in Trust Account
      10,005,563       350,073,997  
  
 
 
    
 
 
  
Total Assets
   
$
12,061,515
 
  
$
350,187,282
 
  
 
 
    
 
 
  
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS’ DEFICIT
     
Current liabilities:
     
Accounts payable
    $ 1,003,857     $ 59,932  
Professional legal fees payable
      1,808,997       —    
Due to related party
      2,591,195       1,158,549  
Accrued expenses
      5,503       998,599  
Income tax payable
      417,095       645,963  
Franchise tax payable
      100,000       394,071  
Legal fee accrual
      2,310,618       3,415,713  
  
 
 
    
 
 
  
Total current liabilities
      8,237,265       6,672,827  
Deferred underwriting fees payable
      1,207,500       1,207,500  
  
 
 
    
 
 
  
Total liabilities
      9,444,765       7,880,327  
  
 
 
    
 
 
  
Commitments and Contingencies
     
Class A common stock subject to possible redemption, $0.0001 par value; 929,456 and 34,500,000 shares at redemption value at September 30, 2023 and December 31, 2022, respectively
      10,005,563       350,073,997  
Stockholders’ deficit
     
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
      —         —    
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 990,000 issued and outstanding (excluding 929,456 shares subject to possible redemption) at September 30, 2023 and December 31, 2022, respectively
      99       99  
Class B common stock, $0.0001 par value; 30,000,000 shares authorized; 5,000,000 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively
      500       500  
Additional
paid-in
capital
      —         —    
Accumulated deficit
      (7,389,412 )      (7,767,641 ) 
  
 
 
    
 
 
  
Total stockholders’ deficit
      (7,388,813 )      (7,767,042 ) 
  
 
 
    
 
 
  
Total Liabilities, Common Stock Subject to Possible Redemption, and Stockholders’ Deficit
   
$
12,061,515
 
  
$
350,187,282
 
  
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
1
KHOSLA VENTURES ACQUISITION CO.
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
 
    
FOR THE THREE MONTHS
ENDED SEPTEMBER 30,
    
FOR THE NINE MONTHS
ENDED SEPTEMBER 30,
  
    
2023
    
2022
    
2023
    
2022
  
General and administrative expenses
    $ 323,495     $ 528,988     $ 1,520,888     $ 1,244,343  
Franchise tax expenses
      40,000       50,000       140,000       150,000  
  
 
 
    
 
 
    
 
 
    
 
 
  
Loss from operations
      (363,495 )      (578,988 )      (1,660,888 )      (1,394,343 ) 
Change in fair value of derivative liabilities
      —         —         —         150,000  
Gain on marketable securities (net), dividends and interest, held in Trust Account
      128,016       1,560,060       7,142,491       2,078,237  
  
 
 
    
 
 
    
 
 
    
 
 
  
Income (loss) before income tax expense
      (235,479 )      981,072       5,481,603       833,894  
  
 
 
    
 
 
    
 
 
    
 
 
  
Income tax expense
      19,907       317,113       1,494,132       366,506  
  
 
 
    
 
 
    
 
 
    
 
 
  
Net income (loss)
    $ (255,386 )    $ 663,959     $ 3,987,471     $ 467,388  
  
 
 
    
 
 
    
 
 
    
 
 
  
Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted
      929,456       34,500,000       20,850,438       34,500,000  
Basic and diluted net income (loss) per share, Class A subject to possible redemption
   
$
0.08
 
  
$
0.02
 
  
$
0.23
 
  
$
0.02
 
Weighted average shares outstanding of Class A
non-redeemable
common stock, basic and diluted
      990,000       990,000       990,000       990,000  
Basic and diluted net loss per share, Class A
non-redeemable
common stock
   
$
(0.06
) 
  
$
(0.02
) 
  
$
(0.12
) 
  
$
(0.04
) 
Weighted average shares outstanding of Class B
non-redeemable
common stock, basic and diluted
      5,000,000       5,000,000       5,000,000       5,000,000  
Basic and diluted net loss per share, Class B
non-redeemable
common stock
   
$
(0.06
) 
  
$
(0.02
) 
  
$
(0.12
) 
  
$
(0.04
) 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
2
KHOSLA VENTURES ACQUISITION CO.
CONDENSED STATEMENTS OF CHANGES IN COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND
STOCKHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023
(Unaudited)
 
    
Common Stock Subject to
Possible Redemption
                  
Common Stock
     
Additional

Paid-In

Capital
     
Accumulated

Deficit
    
Total

Stockholders’

Deficit
  
    
Class A
    
Class A
     
Class B
  
    
Shares
    
Amount
    
Shares
     
Amount
     
Shares
     
Amount
  
Balance as of January 1, 2023
      34,500,000     $ 350,073,997       990,000      $ 99        5,000,000      $ 500      $ —      $ (7,767,641 )    $ (7,767,042 ) 
Accretion of Class A common stock to redemption value
      —         3,743,046       —          —          —          —          —          (3,743,046 )      (3,743,046 ) 
Net income
      —         —         —          —          —          —          —          2,145,323       2,145,323  
  
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance as of March 31, 2023 (unaudited)
   
 
34,500,000
 
  
$
353,817,043
 
  
 
990,000
 
   
$
99
 
   
 
5,000,000
 
   
$
500
 
   
$
—  
     
$
(9,365,364
) 
  
$
(9,364,765
) 
Redemption of Class A common stock
      (33,570,544 )      (343,677,676 )      —          —          —          —          —          —         —    
Reduction to redemption value for estimated tax payment due from redemptions
      —         (3,533,249 )      —          —          —          —          —          3,533,249       3,533,249  
Accretion of Class A common stock to redemption value
      —         3,271,429       —          —          —          —          —          (3,271,429 )      (3,271,429 ) 
Net income
      —         —         —          —          —          —          —          2,097,534       2,097,534  
  
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance as of June 30, 2023 (unaudited)
   
 
929,456
 
  
$
9,877,547
 
  
 
990,000
 
   
$
99
 
   
 
5,000,000
 
   
$
500
 
   
$
—  
     
$
(7,006,010
) 
  
$
(7,005,411
) 
Accretion of Class A common stock to redemption value
      —         128,016       —          —          —          —          —          (128,016 )      (128,016 ) 
Net loss
      —         —         —          —          —          —          —          (255,386 )      (255,386 ) 
  
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance as of September 30, 2023 (unaudited)
   
 
929,456
 
  
$
10,005,563
 
  
 
990,000
 
   
$
99
 
   
 
5,000,000
 
   
$
500
 
   
$
—  
     
$
(7,389,412
) 
  
$
(7,388,813
) 
  
 
 
    
 
 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022
(Unaudited)
 
    
Common Stock Subject to
Possible Redemption
                   
Common Stock
     
Additional

Paid-In

Capital
     
Accumulated

Deficit
    
Total

Stockholders’

Deficit
  
    
Class A
     
Class A
     
Class B
  
    
Shares
     
Amount
     
Shares
     
Amount
     
Shares
     
Amount
  
Balance as of January 1, 2022
   
 
34,500,000
 
   
$
345,017,029
 
   
 
990,000
 
   
$
99
 
   
 
5,000,000
 
   
$
500
 
   
$
—  
     
$
(15,451,798
) 
  
$
(15,451,199
) 
Accretion of Class A common stock to redemption value
      —          28,158        —          —          —          —          —          (28,158 )      (28,158 ) 
Net loss
      —          —          —          —          —          —          —          (243,037 )      (243,037 ) 
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance as of March 31, 2022 (unaudited)
   
 
34,500,000
 
   
$
345,045,187
 
   
 
990,000
 
   
$
99
 
   
 
5,000,000
 
   
$
500
 
   
$
—  
     
$
(15,722,993
) 
  
$
(15,722,394
) 
Accretion of Class A common stock to redemption value
      —          490,019        —          —          —          —          —          (490,019 )      (490,019 ) 
Net income
      —          —          —          —          —          —          —          46,466       46,466  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance as of June 30, 2022 (unaudited)
   
 
34,500,000
 
   
$
345,535,206
 
   
 
990,000
 
   
$
99
 
   
 
5,000,000
 
   
$
500
 
   
$
—  
     
$
(16,166,546
) 
  
$
(16,165,947
) 
Deferred underwriting fees waiver
      —          —          —          —          —          —          —          10,867,500       10,867,500  
Accretion of Class A common stock to redemption value
      —          1,560,060        —          —          —          —          —          (1,560,060 )      (1,560,060 ) 
Net income
      —          —          —          —          —          —          —          663,959       663,959  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance as of September 30, 2022 (unaudited)
   
 
34,500,000
 
   
$
347,095,266
 
   
 
990,000
 
   
$
99
 
   
 
5,000,000
 
   
$
500
 
   
$
—  
     
$
(6,195,147
) 
  
$
(6,194,548
) 
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
3
KHOSLA VENTURES ACQUISITION CO.
STATEMENTS OF CASH FLOWS
(Unaudited)
 
    
FOR THE NINE MONTHS
ENDED SEPTEMBER 30,
2023
    
FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 2022
  
Cash Flows from Operating Activities
     
Net income
    $ 3,987,471     $ 467,388  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
     
Dividends and interest, held in Trust Account
      —         (2,078,237 ) 
Change in fair value of derivative liabilities
      —         (150,000 ) 
Changes in operating assets and liabilities:
     
Prepaid expenses
      (28,479 )      480,741  
Accounts payable and accrued expenses (including franchise tax payable and income tax payable)
      (572,110 )      615,801  
Professional legal fees payable
      703,902       —    
  
 
 
    
 
 
  
Net cash provided by (used in) operating activities
      4,090,784       (664,307 ) 
  
 
 
    
 
 
  
Cash Flows from Investing Activities
     
Investment of marketable securities held in Trust Account
      (7,142,491 )      —    
Trust Account withdrawal-redemption
      343,677,676       —    
Trust Account
withdrawal-tax
payment
      3,533,249       —    
  
 
 
    
 
 
  
Net cash provided by investing activities
      340,068,434       —    
  
 
 
    
 
 
  
Cash Flows from Financing Activities
     
Advances from related party
      1,432,646       462,062  
Redemption of Class A common stock
      (343,677,676 )      —    
  
 
 
    
 
 
  
Net cash (used in) provided by financing activities
      (342,245,030 )      462,062  
  
 
 
    
 
 
  
Net increase (decrease) in cash and restricted cash
      1,914,188       (202,245 ) 
Cash and restricted cash—beginning of period
      —         202,245  
  
 
 
    
 
 
  
Cash and restricted cash—end of period
    $ 1,914,188     $ —  
  
 
 
    
 
 
  
Supplemental disclosure of cash flow information:
     
Cash paid for income taxes
    $ 1,723,000     $ 0  
Supplemental disclosure of noncash investing and financing activities:
     
Accretion of Class A common stock to redemption value
    $ 7,142,491   $ 2,078,237  
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
4
KHOSLA VENTURES ACQUISITION
CO. NOTES TO FINANCIAL
STATEMENTS
Note 1—Description of Organization, Business Operations and Going Concern
Khosla Ventures Acquisition Co. (the “Company”) is a blank check company formed as a Delaware corporation on January 15, 2021. The Company was incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”).
As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company’s formation, its initial public offering (the “IPO”), and the Company’s search for a target to consummate a Business Combination, which are all described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from its initial public offering.
The Company’s sponsor is Khosla Ventures SPAC Sponsor LLC (the “Sponsor”). The Company’s ability to commence operations is contingent upon obtaining adequate financial resources. On March 8, 2021, the Company consummated its IPO of 30,000,000 shares of Class A common stock of the Company, par value $0.0001 per share (each, a “Public Share”), excluding additional Public Shares sold pursuant to the full exercise of the underwriters’ option to purchase additional Public Shares to cover over-allotments. The Public Shares were sold at a price of $10.00 per Public Share, generating gross proceeds to the Company of $300,000,000. On March 8, 2021, the Company’s underwriters exercised in full their option to purchase additional Public Shares in connection with the IPO. The underwriters exercised their option to purchase an additional 4,500,000 Public Shares from the Company at a price of $10.00 per share less the underwriting fees payable. In total, the Company sold 34,500,000 Public Shares in connection with its IPO for gross proceeds of $345,000,000. The underwriters designated March 8, 2021 as the settlement date for such additional Public Shares pursuant to the Underwriting Agreement.
Simultaneously with the closing of the IPO, the Company completed the private sale of 990,000 shares of Class A common stock of the Company, par value $0.0001 per share (the “Private Placement Shares”) at a purchase price of $10.00 per Private Placement Shares, to the Sponsor, generating aggregate gross proceeds to the Company of $9,900,000.
Following the closing of the IPO on March 8, 2021, and the full exercise of the underwriters’ overallotment option on March 8, 2021, an amount of $345,000,000 ($10.00 per Public Share) of the proceeds from the IPO, including $12,075,000 of the underwriting fees payable was placed in a U.S.-based Trust Account at Goldman Sachs, maintained by Continental Stock Transfer & Trust Company, LLC, acting as trustee (“Trust Account”). Except with respect to interest earned on the funds in the Trust Account that may be released to the Company to pay its franchise and income taxes and expenses relating to the administration of the Trust Account, the proceeds from the IPO, including proceeds from the sale of Private Placement Shares and forward purchase shares, which are held in the Trust Account will not be released until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company’s Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of its obligation to redeem 100% of its public shares if the Company does not complete its initial business combination within 27 months from the closing of the IPO or (ii) with respect to any other provisions relating to stockholders’ rights or
pre-initial
business combination activity, and (c) the redemption of all of the Company’s public shares if it is unable to complete its business combination within 27 months from the closing of the IPO, subject to applicable law.
On September 21, 2022, the Company received an executed deferred underwriting fees waiver letter from Goldman Sachs & Co. LLC, informing the Company of its decision to waive any entitlement it may have to its deferred underwriting fees payable held in the Trust Account in respect of any Business Combination. The waiver does not cover deferred underwriting fees payable to Piper Sandler & Co. (representing 10% of the total deferred underwriting fees payable).
The Company’s management has broad discretion with respect to the specific application of the net proceeds of its IPO and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial business combination must be with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting fees payable and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial business combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise is not required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the IPO, management has agreed that an amount equal to at least $10.00 per Public Share sold in the IPO, including the proceeds
 
5
from the sale of the Private Placement Shares and the sale of forward purchase shares, will be held in the Trust Account and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations.
The Company will provide its holders of the Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The
per-share
amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting fees payable the Company will pay to the underwriters. These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to the Amended and Restated Certificate of Incorporation, which was adopted by the Company upon the consummation of the IPO (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transactions is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the transaction. If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Founder Shares prior to this IPO (the “Initial Stockholders”) have agreed to vote their Founder Shares and any Public Shares purchased during or after the IPO in favor of a Business Combination. In addition, the Initial Stockholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
Notwithstanding the foregoing, the Company’s Amended and Restated Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A common stock sold in the IPO, without the prior consent of the Company.
On February 10, 2023, the Company entered into a
non-binding
letter of intent for a potential initial business combination with another company. On June 2, 2023, the Company determined it no longer intends to pursue a potential initial business combination with the counterparty to the letter of intent.
On June 6, 2023, a special meeting of stockholders was held, as a result of which the Company and Continental Stock Transfer & Trust Company entered into Amendment No. 1 (the “IMTA Amendment”) to the Investment Management Trust Agreement, dated March 8, 2021 (the “IMTA”). The IMTA Amendment extended the date by which the Company must complete a business combination to December 8, 2023 from June 8, 2023. If the Company is unable to complete the potential initial business combination by December 8, 2023 (33 months from the closing of the IPO) (the “Combination Period”), and the stockholders have not amended the certificate of incorporation to extend such period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the public shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes as well as expenses relating to the administration of the Trust Account (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding public shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
On June 12, 2023, 33,570,544 shares of Class A common stock were exercised by stockholders for their right to redeem at approximately $10.237 per share. Accordingly, as of September 30, 2023, 929,456 shares of Class A common stock subject to possible redemption were outstanding.
 
6
The Initial Stockholders have agreed not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period or (B) with respect to any other provision relating to stockholders’ rights or
pre-initial
business combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
The Initial Stockholders’ have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders should acquire Public Shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting fees payable held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
On August 18, 2023, the Company received a letter (the “Nasdaq Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires that the Company’s listed securities maintain a minimum Market Value of Listed Securities (“MVLS”) of $35 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company is entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5550(b)(2), which compliance period will expire on February 14, 2024. The Company is working to comply with Nasdaq’s MVLS requirements as set forth in the Nasdaq Listing Rule 5550(b)(2) within the compliance period provided by Nasdaq.
Going Concern and Liquidity
As of September 30, 2023, the Company had $1,914,188 in its operating bank account, out of which $1,664,188 is classified as restricted cash for estimated income and franchise tax payments due to redemptions of the Class A common stock. The Company had a working capital deficit of $6,181,313. For the nine months ended September 30, 2023, $7,142,491 of the amount on deposit in the Trust Account represented the gain on marketable securities (net), dividends and interest, held in Trust Account, which is available for payment of franchise taxes and expenses in connection with the liquidation of the Trust Account. In addition, the Working Capital Loan and advances from related parties are available to the Company to fund operations.
 
7
If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.
As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity conditions raise substantial doubt about the Company’s ability to continue as a going concern through approximately one year from the date of filing. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
Global economic conditions have been worsening, and volatility in, the credit and financial markets and rising inflation and interest rate in the U.S. If these conditions persist and deepen, the Company could experience an inability to access additional capital, or our liquidity could otherwise be impacted. Management continues to evaluate the impact related to rising interest rates and current market condition and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and results of its operations, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The credit and financial markets have experienced extreme volatility and disruptions due to the current conflict between Ukraine and Russia. The conflict is expected to have further global economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences, including those we cannot yet predict, may cause our business, financial condition, results of operations and the price of our ordinary shares to be adversely affected.
Note 2—Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for the period presented.
The interim results for the period ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such an election to opt out
 
8
is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Cash, Cash Equivalents and Restricted Cash
The Company considers all short-term investments with a
n original ma
turity of three months or less when purchased to be cash equivalents. The Company had $1,914,188 total in cash but no cash equivalents as of September 30, 2023. Out of the total cash balance, $1,664,188 is classified as restricted cash as those funds will be used for estimated income and franchise tax payments. Withdrawals from the Trust Account are legally restricted for the redemption of common stock, payment of taxes, and payment of expenses in connection with liquidation. This restricted cash is not available to the Company for working capital purposes. The Company had no cash or cash equivalents as of December 31, 2022.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported on the condensed balance sheets that total to the amounts shown on the condensed statements of cash flows.
 
    
September 30, 2023
     
December 31, 2022
  
Cash and cash equivalents
    $ 250,000      $ —    
Restricted cash for income and franchise tax payments
      1,664,188        —    
    
 
 
     
 
 
  
Total cash and cash equivalents and restricted cash
    $ 1,914,188      $ —    
    
 
 
     
 
 
  
Marketable Securities Held in Trust Account
The Company’s portfolio of investments held in the Trust Account are comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities, dividends and interest held in the Trust Account in the accompanying statements of operations. The fair value for trading securities is determined using quoted market prices in active markets. For the nine months ended September 30, 2023, $
343,677,676
and $
3,533,249
have
been withdrawn from the Trust Account for Class A common stock redemptions as well as tax payments respectively.
Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance
in
ASC Topic 480.
Conditionally redeemable common stock (including
common
stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption are classified as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.
The Class A common stock subject to possible redemption are subject to the subsequent measurement guidance in ASC Topic
480-10-S99
“Distinguishing Liabilities from Equity”. Under such guidance, the Company must subsequently measure the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying amount of the common stock is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the common stock subject to possible redemption to their redemption amount (i.e., $10.00 per share) immediately as if the end of the first reporting period after the IPO, March 8, 2021, was the redemption date. Such changes are reflected in additional
paid-in
capital, or in the absence of additional
paid-in
capital, in accumulated deficit. For the three and nine months ended September 30, 2023, the Company recorded an accretion of $128,016 and $7,142,491, respectively, all of which was recorded in accumulated deficit. For the three and nine months ended September 30, 2022, the Company recorded an accretion of $1,560,060 and $2,078,237, respectively, all of which was recorded in accumulated deficit. The Company withdrew $0 and $3,533,249 for the three and nine months ended September 30, 2023, from the Trust Account to pay income and franchise taxes. This was recorded against accumulated deficit. No such income and franchise tax withdrawals occurred from the Trust Account for the three and nine months ended September 30, 2022.
 
9
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage. As of September 30, 2023 and December 31, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Derivative Financial Instruments
The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period.
Fair Value Measurements
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets.
The fair value hierarchy is categorized into three levels based on the inputs as follows:
 
  •  
Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
 
  •  
Level 2: Observable inputs other than Level 1 inputs. Example of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
 
  •  
Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The fair value of the Company’s financial assets and liabilities, approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Income Taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company’s management determined that the United States is the Company’s only major tax jurisdiction.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
 
10
Net Income (Loss) Per Share of Common Stock
Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock outstanding during the period, excluding common stock shares subject to forfeiture.
Class K common stock will convert into Class A common stock after the initial Business Combination only to the extent certain triggering events occur prior to the 10th anniversary of the initial Business Combination, including three equal triggering events based on the Company’s stock trading at $30.00, $40.00 and $50.00 per share following the first anniversary of the closing of the initial Business Combination and also upon specified strategic transactions. The Company has not considered the effect of the Class K common stock in the calculation of diluted net income (loss) per share since the conversion of Class K common stock into Class A common stock is contingent upon the occurrence of future events.
Class B Founder Shares and Private Placement Shares are included in the calculation of
non-redeemable
net loss per share.
The Company’s statements of operations include a presentation of loss per share for shares of common stock subject to possible redemption in a manner similar to the
two-class
method of loss per share. With respect to the accretion of the Class A common stock subject to possible redemption and consistent with ASC Topic
480-10-S99-3A,
the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net income (loss) per common stock. As of September 30, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per share is the same as basic loss per share for the periods presented.
A reconciliation of net income (loss) per common stock is as follows:
 
    
For The Nine
Months Ended
September 30, 2023
     
For The Nine
Months Ended
September 30, 2022
  
Net income
    $ 3,987,471      $ 467,388  
Accretion of temporary equity in excess of fair value
      (7,142,491 )       (2,078,237 ) 
  
 
 
     
 
 
  
Net income including accretion of temporary equity in excess of fair value
    $ (3,155,020 )     $ (1,610,849 ) 
  
 
 
     
 
 
  
 
    
For The Nine Months Ended September 30, 2023
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (2,450,912 )     $ (116,372 )     $ (587,736 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      7,142,491        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 4,691,579      $ (116,372 )     $ (587,736 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      20,850,438        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.23      $ (0.12 )     $ (0.12 ) 
 
    
For The Nine Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (1,372,544 )     $ (39,386 )     $ (198,919 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      2,078,237        —          —    
  
 
 
     
 
 
     
 
 
  
 
11
    
For The Nine Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Allocation of net income
 
(loss) and deemed dividend
    $ 705,693      $ (39,386 )     $ (198,919 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      34,500,000        990,000        5,000,000  
Basic and diluted net income
 
(loss) per share
    $ 0.02      $ (0.04 )     $ (0.04 ) 
 
12
    
For The Three
Months Ended
September 30, 2023
     
For The Three
Months Ended
September 30, 2022
  
Net income (loss)
    $ (255,386 )     $ 663,959  
Accretion of temporary equity in excess of fair value
      (128,016 )       (1,560,060 ) 
  
 
 
     
 
 
  
Net loss including accretion of temporary equity in excess of fair value
    $ (383,402 )     $ (896,101 ) 
  
 
 
     
 
 
  
 
    
For The Three Months Ended September 30, 2023
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (51,500 )     $ (54,855 )     $ (277,046 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      128,016        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 76,516      $ (54,855 )     $ (277,046 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      929,456        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.08      $ (0.06 )     $ (0.06 ) 
 
    
For The Three Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (763,534 )     $ (21,910 )     $ (110,657 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      1,560,060        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 796,526      $ (21,910 )     $ (110,657 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      34,500,000        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.02      $ (0.02 )     $ (0.02 ) 
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.
Note 3—Related Party Transactions
Due to Related Party
An affiliate of the Sponsor paid certain operating costs on behalf of the Company. These advances are due on demand and
non-interest
bearing. During the nine months ended September 30, 2023 and 2022, the related party paid $1,432,646 and $462,062 of
 
13
operating costs on behalf of the Company, respectively. During the three months ended September 30, 2023 and 2022, the related party paid $0 and $52,648 of operating costs on behalf of the Company, respectively. As of September 30, 2023 and December 31, 2022, the amount due to the related party was $2,591,195 and $1,158,549, respectively.
Founder Shares
On January 19, 2021, the Sponsor acquired 10,000,000 Founder Shares (the “Founder Shares”) for an aggregate purchase price of $25,000, consisting of 5,000,000 Class B Founder Shares (also known as “Class B common stock”) and 5,000,000 Class K Founder Shares (also known as “Class K common stock”). Prior to the initial investment in the Company of $25,000 by the Sponsor, the Company had no assets, tangible or intangible. The per share purchase price of the Founder Shares was determined by dividing the amount of cash contributed to the Company by the aggregate number of Founder Shares issued. On February 28, 2021, the Sponsor entered into a security assignment agreement with six of the Company’s independent directors and assigned 240,000 shares of Class B Founder Shares at an aggregate price of $600.
Class B Founder Shares
The Class B Founder Shares will automatically convert into shares of Class A common stock on the first business day following the completion of our initial Business Combination, at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Class B Founder Shares will equal, in the aggregate on an
as-converted
basis, 15% of the sum of (i) the total number of all shares of Class A common stock issued and outstanding upon completion of this offering (including any over-allotment shares if the underwriters exercise their overallotment option), plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion of the Class B Founder Shares plus (iii) unless waived, the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding (x) any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, deemed issued, or to be issued, to any seller in the initial Business Combination, (y) any shares of Class A common stock issuable upon conversion of the Class K Founder Shares and (z) any Private Placement Shares. Prior to our initial Business Combination, only holders of shares of our Class B common stock will be entitled to vote on the appointment of directors.
Class K Founder Shares
The Class K Founder Shares will convert into shares of Class A common stock after the initial Business Combination only to the extent certain triggering events occur prior to the 10th anniversary of the initial Business Combination, including three equal triggering events based on our stock trading at $30.00, $40.00 and $50.00 per share following the first anniversary of the closing of our initial Business Combination and also upon specified strategic transactions, in each case, as described in this prospectus. The Class K Founder Shares will be convertible into shares of Class A common stock at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares (including both Class B Founder Shares and Class K Founder Shares) will equal, in the aggregate on an
as-converted
basis, 30% of the sum of (i) the total number of all shares of Class A common stock issued and outstanding upon completion of this offering (including any over-allotment shares if the underwriters exercise their overallotment option), plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion of the Class B Founder Shares and Class K Founder Shares plus (iii) unless waived, the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding (x) any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, deemed issued, or to be issued, to any seller in the initial Business Combination and (y) any Private Placement Shares. Prior to our initial Business Combination, only holders of shares of our Class B common stock were entitled to vote on the appointment of directors.
The Company accounts for the Class K Founder Shares as equity linked instruments. Based on the guidance in ASC Topic 815, certain adjustments to the settlement amount of the Class K Founder Shares are based on a variable that is not an input to the fair value of a
“fixed-for-fixed”
option as defined under ASC Topic
815-40
“Derivatives and Hedging”. The Class K Founder Shares are recorded as liabilities as these shares are not considered indexed to the Company’s own stock and not eligible for an exception from derivative accounting.
Working Capital Loans
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans
 
14
out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.
Private Placement Shares
Simultaneously with the closing of the IPO, the Sponsor has purchased 990,000 Class A common stock at a price of $10.00 per share in a private placement for an aggregate purchase price of $9,900,000. The Private Placement Shares are identical to the shares of Class A common stock shares sold in this offering, subject to certain limited exceptions. The Private Placement Shares holders do not have the option to redeem their Class A common stock and as a result, the proceeds received in connection with the IPO are excluded from temporary equity. The par value of these shares and related additional paid in capital are classified as permanent equity in the Company’s financial statements.
The Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares until 30 days after the completion of the initial Business Combination.
Forward Purchase Agreement
The Company has entered into a forward-purchase agreement pursuant to which the Sponsor agreed to purchase an aggregate of up to 2,500,000 shares of our Class A common stock (the “forward-purchase shares”) for $10.00 per share, or an aggregate maximum amount of $25,000,000, in a private placement that would close simultaneously with the closing of the initial Business Combination. The proceeds from the sale of these forward- purchase shares, together with the amounts available to the Company from the Trust Account (after giving effect to any redemptions of public shares) and any other equity or debt financing obtained by the Company in connection with the Business Combination, will be used to satisfy the cash requirements of the Business Combination, including funding the purchase price and paying expenses and retaining specified amounts to be used by the post-Business Combination company for working capital or other purposes. To the extent that the amounts available from the Trust Account and other financing are sufficient for such cash requirements, the Sponsor (together with any permitted transferees under the forward-purchase agreement) may purchase less than 2,500,000 forward-purchase shares. The forward-purchase shares would be identical to the public shares being sold in this offering, except the forward-purchase shares would be subject to transfer restrictions and certain registration rights, as described herein. The Company performed an assessment in accordance with ASC Topic 480, and ASC Topic 815 to conclude whether the forward-purchase shares constitute a liability and a derivative such that it will be fair valued separately from the Company’s common stock. The Company concludes that the forward-purchase shares should be equity-classified and its embedded features should not be bifurcated.
Note 4—Commitments & Contingencies
Registration Rights
The holders of the Founder Shares and Private Placement Shares are entitled to registration rights pursuant to the registration agreement signed prior to the consummation of the IPO. The holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statements to become effective until termination of the applicable
lock-up
period.
Underwriting Agreement
The Company granted the underwriters an option to cover over-allotments and for market stabilization purposes. The over-allotment option entitled the underwriters to purchase on a pro rata basis up to 4,500,000 additional Public Shares at the IPO price, less the underwriting fees payable. On March 8, 2021, the Company’s underwriters exercised in full their option to purchase additional Public Shares in connection with the IPO. The underwriters exercised their option to purchase 4,500,000 Public Shares from the Company at a price of $10.00 per share less the underwriting fees payable. This transaction settled on March 8, 2021.
On September 21, 2022, the Company received an executed deferred underwriting fees waiver letter from Goldman Sachs & Co. LLC, informing the Company of its decision to waive any entitlement it may have to its deferred underwriting fees payable held in the Trust Account in respect of any Business Combination. The waiver does not cover deferred underwriting fees payable to Piper Sandler & Co. (representing 10% of the total deferred underwriting fees payable).
 
15
Note 5—Stockholders’ Deficit
Preferred Stock—The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.
Class A Common Stock—The Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of September 30, 2023 and December 31, 2022, there were 990,000 shares of Class A common stock issued and outstanding, excluding 929,456 and 34,500,000 shares of common stock subject to possible redemption at September 30, 2023 and December 31, 2022, respectively.
Class B Common Stock—The Company is authorized to issue 30,000,000 shares of Class B common stock with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022 there were 5,000,000 shares of Class B common stock issued and outstanding.
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the stockholders except as required by law.
Note 6—Fair Value Measurements
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023 including the fair value hierarchy of the valuation inputs that the Company utilized to determine such fair value.
 
    
Level 1
     
Level 2
     
Level 3
     
Total
  
Assets
            
Marketable securities held in Trust Account
    $ 10,005,563      $ —      $ —      $ 10,005,563  
Liabilities:
            
Class K Founder Shares derivative liabilities
    $ —      $ —      $ —      $ —  
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022 including the fair value hierarchy of the valuation inputs that the Company utilized to determine such fair value.
 
    
Level 1
     
Level 2
     
Level 3
     
Total
  
Assets
            
Marketable securities held in Trust Account
    $ 350,073,997      $ —      $ —      $ 350,073,997  
Liabilities:
            
Class K Founder Shares derivative liabilities
    $ —      $ —      $ —      $ —  
Class K Founder Shares Derivative Liabilities
Class K Founder Shares is accounted for as liabilities in accordance with ASC Topic 815 and presented as derivative liabilities on the accompanying September 30, 2023 and December 31, 2022 balance sheets. The derivative liabilities were measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of derivative liabilities in the statements of operations. In order to capture the market conditions associated with the Class K Founder Shares derivative liabilities, the Company applied an approach that incorporated a Monte Carlo simulation, which involved random iterations of future stock-price paths over the contractual life of the Class K Founder Shares. Based on assumptions regarding potential changes in control of the Company, and the probability distribution of outcomes, the payoff to the holder was determined based on the achievement of the various market thresholds within each simulated path. The present value of the payoff in each simulated trial is calculated, and the fair value of the liabilities is determined by taking the average of all present values.
The Company believes the Class K Founder Shares have not materially changed since prior quarter. As such, no valuation is performed as of September 30, 2023 and the Company concluded that the liabilities related to the Class K Founder Shares is zero.
The key inputs into the Monte-Carlo simulation model for the Class K Founder Shares derivative liabilities were as follows as of December 31, 2022.
 
16
Input
   
December 31, 2022
  
Risk-free interest rate
      3.90 % 
Term to business combination
      0.6 years  
Expected volatility
      de minimis  
Stock price
    $ 9.98  
Dividend yield
      0.00 % 
As of September 30, 2023, the fair value of the Class K Founder S
hares
derivative liabilities, a Level 3 liability, remains $0. In addition, there were no transfers to and from Levels 1, 2, and 3 for the three and nine months ended September 30, 2023.
There were no transfers to and from Levels 1, 2, and 3 for the three and nine months ended September 30, 2022.
Note 7—Income Taxes
The Company’s taxable income primarily consists of interest income on the Trust Account, less any franchise taxes. The Company’s formation costs are generally considered
start-up
costs and are not currently deductible.
The Company recorded an income tax provision of $1,494,132 and $366,506 for the nine months ended September 30, 2023 and 2022, respectively. The effective income tax rate were 27.26% and 43.95% for the nine months ended September 30, 2023 and 2022, respectively. The 27.26% effective income tax rate differs from the federal statutory rate of 21% due to the impact of nondeductible expenses and valuation allowances on deferre
d tax ass
ets. As of September 30, 2023 and December 31, 2022, the Company had $0 of U.S. federal and state net operating loss carryovers available to offset future taxable income, respectively.
In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of deferred tax assets and therefore established a full valuation allowance of $1,900,423 and $1,388,159 as of September 30, 2023, and 2022, respectively.
The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. There were no unrecognized tax benefits as of September 30, 2023 and December 31, 2022. No amounts were accrued for the payment of interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
 
17

Table of Contents
Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Khosla Ventures Acquisition Co. References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsor” refer to Khosla Ventures SPAC Sponsor LLC.

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ

 

18

Table of Contents

materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward- looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company formed under the laws of the State of Delaware on January 15, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our initial Business Combination using cash from the proceeds of the IPO and the sale of the Private Placement Shares and forward-purchase shares, our capital stock, debt or a combination of cash, stock and debt. We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.

Our sponsor is Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company. The registration statement for our IPO was declared effective on March 3, 2021. On March 8, 2021, we consummated our IPO of 34,500,000 Public Shares at $10.00 per share, generating gross proceeds of $345,000,000, and incurring offering costs of $19,660,260, inclusive of $12,075,000 in deferred underwriting fees payable.

Simultaneously with the closing of the IPO, we consummated the private placement of 990,000 Private Placement Shares at a price of $10.00 per private placement share to the sponsor, generating proceeds of $9,900,000.

Upon the closing of the IPO and the private placement, the $345,000,000 of net proceeds from the IPO and certain of the proceeds of the private placement were placed in the Trust Account located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.

On February 10, 2023, we entered into a non-binding letter of intent for a potential initial business combination with another company. On June 2, 2023, the Company determined it no longer intends to pursue a potential initial business combination with the counterparty to the letter of intent.

On June 6, 2023, a special meeting of stockholders was held, as a result of which we and Continental Stock Transfer & Trust Company entered into the IMTA Amendment to the IMTA, dated as of March 8, 2021. The IMTA Amendment extended the date by which we must complete a business combination to December 8, 2023 from June 8, 2023. We expect to announce additional details regarding the potential initial business combination if and when a definitive agreement is executed. No assurances can be made that we will successfully negotiate and enter into a definitive agreement with respect to the potential initial business combination, or that it will be consummated on the terms or timeframe currently contemplated, or at all. However, currently, we are not actively pursuing an initial business combination and do not expect to consummate an initial business combination before December 8, 2023. Any transaction is subject to board and equity holder approval of both companies, regulatory approvals and other customary conditions. If we are unable to complete the potential initial business combination by December 8, 2023 (33 months from the closing of the IPO), and our stockholders have not amended the certificate of incorporation to extend such period, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes as well as expenses relating to the administration of the Trust Account (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding public shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

On June 12, 2023, stockholders exercised their right to redeem 33,570,544 shares of Class A common stock at a price of approximately $10.237 per share. Accordingly, as of September 30, 2023, 929,456 shares of Class A common stock subject to possible redemption were outstanding.

 

19

Table of Contents

On August 18, 2023, we received the Nasdaq Letter from the Listing Qualifications staff of Nasdaq notifying us that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires that the Company’s listed securities maintain a minimum MVLS of $35 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), we are entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5550(b)(2), which compliance period will expire on February 14, 2024. We are working to comply with Nasdaq’s MVLS requirements as set forth in the Nasdaq Listing Rule 5550(b)(2) within the compliance period provided by Nasdaq.

Results of Operations and Known Trends or Future Events

We have neither engaged in any operations (other than searching for a Business Combination after our IPO) nor generated any revenues to date. Our only activities from January 15, 2021 (inception) through September 30, 2023 were organizational activities and those necessary to prepare for the IPO and the proposed initial Business Combination. We do not expect to generate any operating revenue until after the completion of our Business Combination. We expect to generate non-operating income in the form of interest income on marketable securities held after the IPO. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended September 30, 2023, we had a loss from operations of $363,495 which consisted of $323,495 of general and administrative expenses and $40,000 in franchise tax expense. Of the $323,495 of general and administrative expenses, $166,250 related to the amortization of Directors’ and Officers’ liability insurance, $54,146 related to legal expenses and $103,099 related to other professional services. We also recorded a $128,016 gain on marketable securities (net), dividends and interest, held in Trust Account, and $19,907 in income tax expense, resulting in net loss of $255,386.

For the three months ended September 30, 2022, we had a loss from operations of $578,988, which consisted of $528,988 of general and administrative expenses and $50,000 in franchise tax expenses. Of the $528,988 of general and administrative expenses, $167,358 was related to the amortization of Directors’ and Officers’ liability insurance, $231,189 was related to legal expense and $130,441 was related to professional services. We also recorded a $1,560,060 gain on marketable securities (net), dividends and interest, held in Trust Account and a $317,113 in income tax expense, resulting in a net income of $663,959.

For the nine months ended September 30, 2023, we had a loss from operations of $1,660,888 which consisted of $1,520,888 of general and administrative expenses and $140,000 in franchise tax expenses. Of the $1,520,888 of general and administrative expenses, $496,289 related to the amortization of Directors’ and Officers’ liability insurance, $703,902 related to legal expenses and $320,697 related to other professional services. We also recorded a $7,142,491 gain on marketable securities (net), dividends and interest, held in Trust Account, and $1,494,132 in income tax expense, resulting in net income of $3,987,471.

For the nine months ended September 30, 2022, we had a loss from operations of $1,394,343, which consisted of $1,244,343 of general and administrative expenses and $150,000 in franchise tax expense. Of the $1,244,343 of general and administrative expenses, $496,617 was related to the amortization of Directors’ and Officers’ liability insurance, $263,221 was related to legal expense and $484,505 was related to additional professional services. We also recorded a $150,000 change in fair value of derivative liabilities, $2,078,237 gain on marketable securities (net), dividends and interest, held in Trust Account and a $366,506 in income expense, resulting in a net income of $467,388.

Liquidity and Capital Resources

As of September 30, 2023, the Company had $1,914,188 in its operating bank account, out of which $1,664,188 is classified as restricted cash for estimated income and franchise tax payments. The Company had a working capital deficit of $6,181,313. As of September 30, 2023, $7,142,491 of the amount on deposit in the Trust Account represented interest income, which is available for payment of franchise taxes and expenses in connection with the liquidation of the Trust Account. In addition, the Working Capital Loan and advances from related parties are available to the Company to fund operations.

If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity conditions raise substantial doubt about the Company’s ability to continue as a going concern through approximately one year from the date of filing. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

20

Table of Contents

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

The underwriters are entitled to a deferred fee of $0.35 per public share, or $12,075,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement.

On September 21, 2022, the Company received an executed deferred underwriting fees waiver letter from Goldman Sachs & Co. LLC, informing the Company of its decision to waive any entitlement it may have to its deferred underwriting fees payable held in the Trust Account in respect of any Business Combination. The waiver does not cover deferred underwriting fees payable to Piper Sandler & Co. (representing 10% of the total deferred underwriting fees payable). The waiver is recorded in the Company’s condensed statements of changes in common stock subject to possible redemption and stockholder’s deficit against accumulated deficit.

On March 3, 2021, we entered into a forward-purchase agreement pursuant to which the sponsor (together with any permitted transferees under the forward-purchase agreement, the “Khosla Entities”) has agreed to purchase an aggregate of up to 2,500,000 forward-purchase shares for $10.00 per share, or an aggregate maximum amount of $25,000,000, in a private placement that will close simultaneously with the closing of the initial Business Combination. The Khosla Entities will purchase a number of forward-purchase shares that will result in gross proceeds to us necessary to enable us to consummate our initial Business Combination and pay related fees and expenses, after first applying amounts available to us from the Trust Account (after paying the underwriting fees payable and giving effect to any redemptions of Public Shares) and any other financing source obtained by us for such purpose at or prior to the consummation of our initial Business Combination, plus any additional amounts mutually agreed by us and the Khosla Entities to be retained by the post-Business Combination company for working capital or other purposes. The Khosla Entities’ obligation to purchase forward-purchase shares will, among other things, be conditioned on the Business Combination (including the target assets or business, and the terms of the Business Combination) being reasonably acceptable to the Khosla Entities and on a requirement that such initial Business Combination is approved by a unanimous vote of our board of directors. In determining whether a target is reasonably acceptable to the Khosla Entities, we expect that the Khosla Entities would consider many of the same criteria as we will consider but will also consider whether the investment is an appropriate investment for the Khosla Entities.

Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. There have been no significant changes in our critical accounting estimates as compared to the critical accounting estimates disclosed in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K filed with the SEC for the fiscal year ended December 31, 2022.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

Item  4.

Controls and Procedures

Evaluation of disclosure controls and procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

21

Table of Contents

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2023, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.

Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that as of September 30, 2023, our disclosure controls and procedures were not effective due to material weaknesses in internal controls over financial reporting related to inaccurate accounting. Management identified errors in its historical financial statements related to the accounting for the Class A common stock, the Class K Founder Shares, and cash flow statement presentation. Because the Class A common stock issued in the IPO can be redeemed or become redeemable subject to the occurrence of future events considered outside of the Company’s control, the Company should have classified all of these redeemable shares in temporary equity and remeasured these redeemable shares to their redemption value (i.e., $10.00 per share) as of the end of the first reporting period after the date of the Company’s IPO. Management also concluded that it incorrectly accounted for the Class K Founder Shares as permanent equity versus derivative liabilities. Management also concluded that it incorrectly presented the gain on marketable securities (net), dividends and interest, held in Trust Account as operating activities in cash flow statement versus investing activities.

To address these material weaknesses, management has devoted, and plans to continue to devote, significant effort and resources to the remediation and improvement of its internal control over financial reporting and to provide processes and controls over the internal communications within the Company, financial advisors and independent registered public accounting firm. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance these processes to better evaluate our research and understanding of the nuances of the complex accounting standards that apply to our financial statements. We plan to provide enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. Following identification of the material weaknesses and prior to filing this Quarterly Report on Form 10-Q, we completed substantive procedures for the period covered by this report. Based on these procedures, management believes that our financial statements included in this report have been prepared in accordance with U.S. generally accepted accounting principles. Our principal executive officer and principal financial and accounting officer have certified that, based on their knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects our financial condition, results of operations and cash flows as of, and for, the periods presented in this report.

Changes in internal control over financial reporting

As of September 30, 2023, we are in the process of implementing changes to our internal control over financial reporting to remediate such material weaknesses, as more fully described above. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. Other than the changes described above, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the fiscal quarter ended September 30, 2023 covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

22

Table of Contents

PART II-OTHER INFORMATION

 

Item 1.

Legal Proceedings.

None.

 

Item 1A.

Risk Factors.

Factors that could cause our actual results to differ materially from those in this report include the risk factors described in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

There were no sales of unregistered securities during the three months ended September 30, 2023.

 

Item 3.

Defaults Upon Senior Securities.

None.

 

Item 4.

Mine Safety Disclosures.

Not Applicable.

 

Item 5.

Other Information.

None.

 

23

Table of Contents
Item 6.

Exhibits.

The following exhibits are filed or furnished as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit

Number

  

Exhibit Description

    Incorporated by Reference      Filed/
Furnished
Herewith		  
   Form      File No.      Exhibit      Filing
Date		  
    3.1(a)   Second Amended and Restated Certificate of Incorporation, dated March 4, 2021      8-K        001-40131        3.1        3/9/21     
    3.1(b)   Amendment to the Second Amended and Restated Certificate of Incorporation, dated March 4, 2021      8-K        001-40131        3.1        6/12/23     
    3.2   Bylaws      S-1        333-253096        3.3        2/12/21     
    4.1   Specimen Class A Common Stock Certificate      S-1        333-253096        4.1        2/12/21     
  31.1   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes- Oxley Act of 2002                  *  
  31.2   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes- Oxley Act of 2002                  *  
  32.1   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002                  **  
  32.2   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002                  **  
101.INS   Inline XBRL Instance Document                  *  
101.SCH   Inline XBRL Taxonomy Extension Schema Document                  *  
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document                  *  
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document                  *  
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document                  *  
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document                  *  
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)               

 

*

Filed herewith.

**

Furnished herewith.

 

24

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    KHOSLA VENTURES ACQUISITION CO.
Date: November 14, 2023     By:  

/s/ Peter Buckland

    Name:   Peter Buckland
    Title:   Chief Financial Officer

 

 

25

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Samir Kaul, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Khosla Ventures Acquisition Co.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2023     By:  

/s/ Samir Kaul

     

Samir Kaul

Chief Executive Officer

(principal executive officer)

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Peter Buckland, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Khosla Ventures Acquisition Co.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2023     By:  

/s/ Peter Buckland

     

Peter Buckland

Chief Financial Officer

(principal financial officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Khosla Ventures Acquisition Co. (the “Company”) for the period ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14, 2023     By:  

/s/ Samir Kaul

     

Samir Kaul

Chief Executive Officer

(principal executive officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Khosla Ventures Acquisition Co. (the “Company”) for the period ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14, 2023     By:  

/s/ Peter Buckland

     

Peter Buckland

Chief Financial Officer

(principal financial officer)

v3.23.3
Cover Page - shares
 9 Months Ended
Sep. 30, 2023
Nov. 14, 2023
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Registrant Name Khosla Ventures Acquisition Co.  
Entity Central Index Key 0001841873  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Trading Symbol KVSA  
Entity Shell Company true  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Interactive Data Current Yes  
Entity Address, State or Province CA  
Title of 12(b) Security Class A common stock, par value $0.0001 per share  
Security Exchange Name NASDAQ  
Entity Incorporation, State or Country Code DE  
Entity File Number 001-40131  
Entity Tax Identification Number 85-1488707  
Entity Address, Address Line One 2128 Sand Hill Road  
Entity Address, City or Town Menlo Park  
Entity Address, Postal Zip Code 94025  
City Area Code 650  
Local Phone Number 376-8500  
Common Class A [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   1,919,456
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   5,000,000
Common Class K [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   5,000,000
v3.23.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 250,000 $ 0
Restricted Cash 1,664,188 0
Prepaid expenses 141,764 113,285
Total current assets 2,055,952 113,285
Marketable securities held in Trust Account 10,005,563 350,073,997
Total Assets 12,061,515 350,187,282
Current liabilities:    
Accounts payable 1,003,857 59,932
Professional legal fees payable 1,808,997 0
Due to related party 2,591,195 1,158,549
Accrued expenses 5,503 998,599
Income tax payable 417,095 645,963
Franchise tax payable 100,000 394,071
Legal fee accrual 2,310,618 3,415,713
Total current liabilities $ 8,237,265 $ 6,672,827
Other Liability, Current, Related Party, Type [Extensible Enumeration] Related Party [Member] Related Party [Member]
Deferred underwriting fees payable $ 1,207,500 $ 1,207,500
Total liabilities 9,444,765 7,880,327
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 929,456 and 34,500,000 shares at redemption value at September 30, 2023 and December 31, 2022, respectively 10,005,563 350,073,997
Stockholders' deficit    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding 0 0
Additional paid-in capital 0 0
Accumulated deficit (7,389,412) (7,767,641)
Total stockholders' deficit (7,388,813) (7,767,042)
Total Liabilities, Common Stock Subject to Possible Redemption, and Stockholders' Deficit 12,061,515 350,187,282
Common Class A [Member]    
Stockholders' deficit    
Common Stock, Value 99 99
Common Class B [Member]    
Stockholders' deficit    
Common Stock, Value $ 500 $ 500
v3.23.3
Condensed Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2023
Jun. 12, 2023
Dec. 31, 2022
Common stock subject to possible redemption 929,456   34,500,000
Preferred Stock Par Value Per Share $ 0.0001   $ 0.0001
Preferred Stock Shares Authorized 1,000,000   1,000,000
Preferred Stock Shares Issued 0   0
Preferred Stock Shares Outstanding 0   0
Common Class A [Member]      
Temporary Equity, Par or Stated Value Per Share $ 0.0001 $ 10.237 $ 0.0001
Common stock subject to possible redemption 929,456   34,500,000
Common Stock Par Value Per Share $ 0.0001   $ 0.0001
Common Stock Shares Authorized 200,000,000   200,000,000
Common Stock Shares Issued 990,000   990,000
Common Stock Shares Outstanding 990,000   990,000
Common Class B [Member]      
Common Stock Par Value Per Share $ 0.0001   $ 0.0001
Common Stock Shares Authorized 30,000,000   30,000,000
Common Stock Shares Issued 5,000,000   5,000,000
Common Stock Shares Outstanding 5,000,000   5,000,000
v3.23.3
Condensed Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
General and administrative expenses $ 323,495 $ 528,988 $ 1,520,888 $ 1,244,343
Franchise tax expenses 40,000 50,000 140,000 150,000
Loss from operations (363,495) (578,988) (1,660,888) (1,394,343)
Change in fair value of derivative liabilities 0 0 0 150,000
Gain on marketable securities (net), dividends and interest, held in Trust Account 128,016 1,560,060 7,142,491 2,078,237
Income (loss) before income tax expense (235,479) 981,072 5,481,603 833,894
Income tax expense 19,907 317,113 1,494,132 366,506
Net income (loss) $ (255,386) $ 663,959 $ 3,987,471 $ 467,388
Common Class A [Member] | Non Redeemable Common Stock [Member]        
Weighted average shares outstanding, basic 990,000 990,000 990,000 990,000
Weighted average shares outstanding, diluted 990,000 990,000 990,000 990,000
Basic net income (loss) per share $ (0.06) $ (0.02) $ (0.12) $ (0.04)
Diluted net income (loss) per share $ (0.06) $ (0.02) $ (0.12) $ (0.04)
Common Class A [Member] | Common Stock Subject To Possible Redemption [Member]        
Net income (loss) $ 76,516 $ 796,526 $ 4,691,579 $ 705,693
Weighted average shares outstanding, basic 929,456 34,500,000 20,850,438 34,500,000
Weighted average shares outstanding, diluted 929,456 34,500,000 20,850,438 34,500,000
Basic net income (loss) per share $ 0.08 $ 0.02 $ 0.23 $ 0.02
Diluted net income (loss) per share $ 0.08 $ 0.02 $ 0.23 $ 0.02
Common Class B [Member] | Non Redeemable Common Stock [Member]        
Weighted average shares outstanding, basic 5,000,000 5,000,000 5,000,000 5,000,000
Weighted average shares outstanding, diluted 5,000,000 5,000,000 5,000,000 5,000,000
Basic net income (loss) per share $ (0.06) $ (0.02) $ (0.12) $ (0.04)
Diluted net income (loss) per share $ (0.06) $ (0.02) $ (0.12) $ (0.04)
v3.23.3
Condensed Statements of Changes In Common Stock Subject to Possible Redemption and Stockholders' Deficit - USD ($)
Total
Common Class A [Member]
Temporary Equity [Member]
Common Class A [Member]
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Beginning Balance at Dec. 31, 2021 $ (15,451,199)   $ 345,017,029 $ 99 $ 500 $ (15,451,798)
Beginning Balance (in shares) at Dec. 31, 2021     34,500,000 990,000 5,000,000    
Accretion of Class A common stock to redemption value (28,158)   $ 28,158     0 (28,158)
Net income (loss) (243,037)           (243,037)
Ending Balance at Mar. 31, 2022 (15,722,394)   $ 345,045,187 $ 99 $ 500 0 (15,722,993)
Ending Balance (in shares) at Mar. 31, 2022     34,500,000 990,000 5,000,000    
Beginning Balance at Dec. 31, 2021 (15,451,199)   $ 345,017,029 $ 99 $ 500 (15,451,798)
Beginning Balance (in shares) at Dec. 31, 2021     34,500,000 990,000 5,000,000    
Accretion of Class A common stock to redemption value   $ (2,078,237)          
Net income (loss) 467,388     $ (39,386) $ (198,919)    
Ending Balance at Sep. 30, 2022 (6,194,548)   $ 347,095,266 $ 99 $ 500 (6,195,147)
Ending Balance (in shares) at Sep. 30, 2022     34,500,000 990,000 5,000,000    
Beginning Balance at Mar. 31, 2022 (15,722,394)   $ 345,045,187 $ 99 $ 500 0 (15,722,993)
Beginning Balance (in shares) at Mar. 31, 2022     34,500,000 990,000 5,000,000    
Accretion of Class A common stock to redemption value (490,019)   $ 490,019     0 (490,019)
Net income (loss) 46,466           46,466
Ending Balance at Jun. 30, 2022 (16,165,947)   $ 345,535,206 $ 99 $ 500 (16,166,546)
Ending Balance (in shares) at Jun. 30, 2022     34,500,000 990,000 5,000,000    
Accretion of Class A common stock to redemption value (1,560,060) (1,560,060) $ 1,560,060     0 (1,560,060)
Deferred Underwriting Fees Waiver 10,867,500           10,867,500
Net income (loss) 663,959     $ (21,910) $ (110,657)   663,959
Ending Balance at Sep. 30, 2022 (6,194,548)   $ 347,095,266 $ 99 $ 500 (6,195,147)
Ending Balance (in shares) at Sep. 30, 2022     34,500,000 990,000 5,000,000    
Beginning Balance at Dec. 31, 2022 (7,767,042)   $ 350,073,997 $ 99 $ 500 (7,767,641)
Beginning Balance (in shares) at Dec. 31, 2022     34,500,000 990,000 5,000,000    
Accretion of Class A common stock to redemption value (3,743,046)   $ 3,743,046     0 (3,743,046)
Net income (loss) 2,145,323           2,145,323
Ending Balance at Mar. 31, 2023 (9,364,765)   $ 353,817,043 $ 99 $ 500 0 (9,365,364)
Ending Balance (in shares) at Mar. 31, 2023     34,500,000 990,000 5,000,000    
Beginning Balance at Dec. 31, 2022 (7,767,042)   $ 350,073,997 $ 99 $ 500 (7,767,641)
Beginning Balance (in shares) at Dec. 31, 2022     34,500,000 990,000 5,000,000    
Accretion of Class A common stock to redemption value   (7,142,491)          
Net income (loss) 3,987,471     $ (116,372) $ (587,736)    
Ending Balance at Sep. 30, 2023 (7,388,813)   $ 10,005,563 $ 99 $ 500 (7,389,412)
Ending Balance (in shares) at Sep. 30, 2023     929,456 990,000 5,000,000    
Beginning Balance at Mar. 31, 2023 (9,364,765)   $ 353,817,043 $ 99 $ 500 0 (9,365,364)
Beginning Balance (in shares) at Mar. 31, 2023     34,500,000 990,000 5,000,000    
Accretion of Class A common stock to redemption value (3,271,429)   $ 3,271,429     0 (3,271,429)
Redemption of Class A common stock     (343,677,676)        
Reduction to redemption value for estimated tax payment due from redemptions 3,533,249   $ (3,533,249)       3,533,249
Redemption of Class A common stock, Shares     (33,570,544)        
Net income (loss) 2,097,534           2,097,534
Ending Balance at Jun. 30, 2023 (7,005,411)   $ 9,877,547 $ 99 $ 500 (7,006,010)
Ending Balance (in shares) at Jun. 30, 2023     929,456 990,000 5,000,000    
Accretion of Class A common stock to redemption value (128,016) $ (128,016) $ 128,016     0 (128,016)
Net income (loss) (255,386)     $ (54,855) $ (277,046)   (255,386)
Ending Balance at Sep. 30, 2023 $ (7,388,813)   $ 10,005,563 $ 99 $ 500 $ (7,389,412)
Ending Balance (in shares) at Sep. 30, 2023     929,456 990,000 5,000,000    
v3.23.3
Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities        
Net income $ (255,386) $ 663,959 $ 3,987,471 $ 467,388
Adjustments to reconcile net income to net cash provided by (used in) operating activities:        
Dividends and interest, held in Trust Account     0 (2,078,237)
Change in fair value of derivative liabilities 0 0 0 (150,000)
Changes in operating assets and liabilities:        
Prepaid expenses     (28,479) 480,741
Accounts payable and accrued expenses (including franchise tax payable and income tax payable)     (572,110) 615,801
Professional legal fees payable     703,902 0
Net cash provided by (used in) operating activities     4,090,784 (664,307)
Cash Flows from Investing Activities        
Investment of marketable securities held in Trust Account     (7,142,491) 0
Trust Account withdrawal-redemption     343,677,676 0
Trust Account withdrawal-tax payment 0 0 3,533,249 0
Net cash provided by investing activities     340,068,434 0
Cash Flows from Financing Activities        
Advances from related party     1,432,646 462,062
Redemption of Class A common stock     (343,677,676) 0
Net cash (used in) provided by financing activities     (342,245,030) 462,062
Net increase (decrease) in cash and restricted cash     1,914,188 (202,245)
Cash and restricted cash - beginning of period     0 202,245
Cash and restricted cash- end of period $ 1,914,188 $ 0 1,914,188 0
Supplemental disclosure of cash flow information:        
Cash paid for income taxes     1,723,000 0
Supplemental disclosure of noncash investing and financing activities:        
Accretion of Class A common stock to redemption value     $ 7,142,491 $ 2,078,237
v3.23.3
Description of Organization, Business Operations and Going Concern
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Organization, Business Operations and Going Concern
Note 1—Description of Organization, Business Operations and Going Concern
Khosla Ventures Acquisition Co. (the “Company”) is a blank check company formed as a Delaware corporation on January 15, 2021. The Company was incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”).
As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company’s formation, its initial public offering (the “IPO”), and the Company’s search for a target to consummate a Business Combination, which are all described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from its initial public offering.
The Company’s sponsor is Khosla Ventures SPAC Sponsor LLC (the “Sponsor”). The Company’s ability to commence operations is contingent upon obtaining adequate financial resources. On March 8, 2021, the Company consummated its IPO of 30,000,000 shares of Class A common stock of the Company, par value $0.0001 per share (each, a “Public Share”), excluding additional Public Shares sold pursuant to the full exercise of the underwriters’ option to purchase additional Public Shares to cover over-allotments. The Public Shares were sold at a price of $10.00 per Public Share, generating gross proceeds to the Company of $300,000,000. On March 8, 2021, the Company’s underwriters exercised in full their option to purchase additional Public Shares in connection with the IPO. The underwriters exercised their option to purchase an additional 4,500,000 Public Shares from the Company at a price of $10.00 per share less the underwriting fees payable. In total, the Company sold 34,500,000 Public Shares in connection with its IPO for gross proceeds of $345,000,000. The underwriters designated March 8, 2021 as the settlement date for such additional Public Shares pursuant to the Underwriting Agreement.
Simultaneously with the closing of the IPO, the Company completed the private sale of 990,000 shares of Class A common stock of the Company, par value $0.0001 per share (the “Private Placement Shares”) at a purchase price of $10.00 per Private Placement Shares, to the Sponsor, generating aggregate gross proceeds to the Company of $9,900,000.
Following the closing of the IPO on March 8, 2021, and the full exercise of the underwriters’ overallotment option on March 8, 2021, an amount of $345,000,000 ($10.00 per Public Share) of the proceeds from the IPO, including $12,075,000 of the underwriting fees payable was placed in a U.S.-based Trust Account at Goldman Sachs, maintained by Continental Stock Transfer & Trust Company, LLC, acting as trustee (“Trust Account”). Except with respect to interest earned on the funds in the Trust Account that may be released to the Company to pay its franchise and income taxes and expenses relating to the administration of the Trust Account, the proceeds from the IPO, including proceeds from the sale of Private Placement Shares and forward purchase shares, which are held in the Trust Account will not be released until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company’s Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of its obligation to redeem 100% of its public shares if the Company does not complete its initial business combination within 27 months from the closing of the IPO or (ii) with respect to any other provisions relating to stockholders’ rights or
pre-initial
business combination activity, and (c) the redemption of all of the Company’s public shares if it is unable to complete its business combination within 27 months from the closing of the IPO, subject to applicable law.
On September 21, 2022, the Company received an executed deferred underwriting fees waiver letter from Goldman Sachs & Co. LLC, informing the Company of its decision to waive any entitlement it may have to its deferred underwriting fees payable held in the Trust Account in respect of any Business Combination. The waiver does not cover deferred underwriting fees payable to Piper Sandler & Co. (representing 10% of the total deferred underwriting fees payable).
The Company’s management has broad discretion with respect to the specific application of the net proceeds of its IPO and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial business combination must be with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting fees payable and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial business combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise is not required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the IPO, management has agreed that an amount equal to at least $10.00 per Public Share sold in the IPO, including the proceeds
 
from the sale of the Private Placement Shares and the sale of forward purchase shares, will be held in the Trust Account and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations.
The Company will provide its holders of the Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The
per-share
amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting fees payable the Company will pay to the underwriters. These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to the Amended and Restated Certificate of Incorporation, which was adopted by the Company upon the consummation of the IPO (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transactions is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the transaction. If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Founder Shares prior to this IPO (the “Initial Stockholders”) have agreed to vote their Founder Shares and any Public Shares purchased during or after the IPO in favor of a Business Combination. In addition, the Initial Stockholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
Notwithstanding the foregoing, the Company’s Amended and Restated Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A common stock sold in the IPO, without the prior consent of the Company.
On February 10, 2023, the Company entered into a
non-binding
letter of intent for a potential initial business combination with another company. On June 2, 2023, the Company determined it no longer intends to pursue a potential initial business combination with the counterparty to the letter of intent.
On June 6, 2023, a special meeting of stockholders was held, as a result of which the Company and Continental Stock Transfer & Trust Company entered into Amendment No. 1 (the “IMTA Amendment”) to the Investment Management Trust Agreement, dated March 8, 2021 (the “IMTA”). The IMTA Amendment extended the date by which the Company must complete a business combination to December 8, 2023 from June 8, 2023. If the Company is unable to complete the potential initial business combination by December 8, 2023 (33 months from the closing of the IPO) (the “Combination Period”), and the stockholders have not amended the certificate of incorporation to extend such period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the public shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes as well as expenses relating to the administration of the Trust Account (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding public shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
On June 12, 2023, 33,570,544 shares of Class A common stock were exercised by stockholders for their right to redeem at approximately $10.237 per share. Accordingly, as of September 30, 2023, 929,456 shares of Class A common stock subject to possible redemption were outstanding.
 
The Initial Stockholders have agreed not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period or (B) with respect to any other provision relating to stockholders’ rights or
pre-initial
business combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
The Initial Stockholders’ have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders should acquire Public Shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting fees payable held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
On August 18, 2023, the Company received a letter (the “Nasdaq Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires that the Company’s listed securities maintain a minimum Market Value of Listed Securities (“MVLS”) of $35 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company is entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5550(b)(2), which compliance period will expire on February 14, 2024. The Company is working to comply with Nasdaq’s MVLS requirements as set forth in the Nasdaq Listing Rule 5550(b)(2) within the compliance period provided by Nasdaq.
Going Concern and Liquidity
As of September 30, 2023, the Company had $1,914,188 in its operating bank account, out of which $1,664,188 is classified as restricted cash for estimated income and franchise tax payments due to redemptions of the Class A common stock. The Company had a working capital deficit of $6,181,313. For the nine months ended September 30, 2023, $7,142,491 of the amount on deposit in the Trust Account represented the gain on marketable securities (net), dividends and interest, held in Trust Account, which is available for payment of franchise taxes and expenses in connection with the liquidation of the Trust Account. In addition, the Working Capital Loan and advances from related parties are available to the Company to fund operations.
 
If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.
As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity conditions raise substantial doubt about the Company’s ability to continue as a going concern through approximately one year from the date of filing. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
Global economic conditions have been worsening, and volatility in, the credit and financial markets and rising inflation and interest rate in the U.S. If these conditions persist and deepen, the Company could experience an inability to access additional capital, or our liquidity could otherwise be impacted. Management continues to evaluate the impact related to rising interest rates and current market condition and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and results of its operations, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The credit and financial markets have experienced extreme volatility and disruptions due to the current conflict between Ukraine and Russia. The conflict is expected to have further global economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences, including those we cannot yet predict, may cause our business, financial condition, results of operations and the price of our ordinary shares to be adversely affected.
v3.23.3
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2—Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for the period presented.
The interim results for the period ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such an election to opt out
 
is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Cash, Cash Equivalents and Restricted Cash
The Company considers all short-term investments with a
n original ma
turity of three months or less when purchased to be cash equivalents. The Company had $1,914,188 total in cash but no cash equivalents as of September 30, 2023. Out of the total cash balance, $1,664,188 is classified as restricted cash as those funds will be used for estimated income and franchise tax payments. Withdrawals from the Trust Account are legally restricted for the redemption of common stock, payment of taxes, and payment of expenses in connection with liquidation. This restricted cash is not available to the Company for working capital purposes. The Company had no cash or cash equivalents as of December 31, 2022.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported on the condensed balance sheets that total to the amounts shown on the condensed statements of cash flows.
 
    
September 30, 2023
     
December 31, 2022
  
Cash and cash equivalents
    $ 250,000      $ —    
Restricted cash for income and franchise tax payments
      1,664,188        —    
    
 
 
     
 
 
  
Total cash and cash equivalents and restricted cash
    $ 1,914,188      $ —    
    
 
 
     
 
 
  
Marketable Securities Held in Trust Account
The Company’s portfolio of investments held in the Trust Account are comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities, dividends and interest held in the Trust Account in the accompanying statements of operations. The fair value for trading securities is determined using quoted market prices in active markets. For the nine months ended September 30, 2023, $
343,677,676
and $
3,533,249
have
been withdrawn from the Trust Account for Class A common stock redemptions as well as tax payments respectively.
Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance
in
ASC Topic 480.
Conditionally redeemable common stock (including
common
stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption are classified as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.
The Class A common stock subject to possible redemption are subject to the subsequent measurement guidance in ASC Topic
480-10-S99
“Distinguishing Liabilities from Equity”. Under such guidance, the Company must subsequently measure the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying amount of the common stock is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the common stock subject to possible redemption to their redemption amount (i.e., $10.00 per share) immediately as if the end of the first reporting period after the IPO, March 8, 2021, was the redemption date. Such changes are reflected in additional
paid-in
capital, or in the absence of additional
paid-in
capital, in accumulated deficit. For the three and nine months ended September 30, 2023, the Company recorded an accretion of $128,016 and $7,142,491, respectively, all of which was recorded in accumulated deficit. For the three and nine months ended September 30, 2022, the Company recorded an accretion of $1,560,060 and $2,078,237, respectively, all of which was recorded in accumulated deficit. The Company withdrew $0 and $3,533,249 for the three and nine months ended September 30, 2023, from the Trust Account to pay income and franchise taxes. This was recorded against accumulated deficit. No such income and franchise tax withdrawals occurred from the Trust Account for the three and nine months ended September 30, 2022.
 
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage. As of September 30, 2023 and December 31, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Derivative Financial Instruments
The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period.
Fair Value Measurements
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets.
The fair value hierarchy is categorized into three levels based on the inputs as follows:
 
  •  
Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
 
  •  
Level 2: Observable inputs other than Level 1 inputs. Example of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
 
  •  
Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The fair value of the Company’s financial assets and liabilities, approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Income Taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company’s management determined that the United States is the Company’s only major tax jurisdiction.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
 
Net Income (Loss) Per Share of Common Stock
Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock outstanding during the period, excluding common stock shares subject to forfeiture.
Class K common stock will convert into Class A common stock after the initial Business Combination only to the extent certain triggering events occur prior to the 10th anniversary of the initial Business Combination, including three equal triggering events based on the Company’s stock trading at $30.00, $40.00 and $50.00 per share following the first anniversary of the closing of the initial Business Combination and also upon specified strategic transactions. The Company has not considered the effect of the Class K common stock in the calculation of diluted net income (loss) per share since the conversion of Class K common stock into Class A common stock is contingent upon the occurrence of future events.
Class B Founder Shares and Private Placement Shares are included in the calculation of
non-redeemable
net loss per share.
The Company’s statements of operations include a presentation of loss per share for shares of common stock subject to possible redemption in a manner similar to the
two-class
method of loss per share. With respect to the accretion of the Class A common stock subject to possible redemption and consistent with ASC Topic
480-10-S99-3A,
the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net income (loss) per common stock. As of September 30, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per share is the same as basic loss per share for the periods presented.
A reconciliation of net income (loss) per common stock is as follows:
 
    
For The Nine
Months Ended
September 30, 2023
     
For The Nine
Months Ended
September 30, 2022
  
Net income
    $ 3,987,471      $ 467,388  
Accretion of temporary equity in excess of fair value
      (7,142,491 )       (2,078,237 ) 
  
 
 
     
 
 
  
Net income including accretion of temporary equity in excess of fair value
    $ (3,155,020 )     $ (1,610,849 ) 
  
 
 
     
 
 
  
 
    
For The Nine Months Ended September 30, 2023
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (2,450,912 )     $ (116,372 )     $ (587,736 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      7,142,491        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 4,691,579      $ (116,372 )     $ (587,736 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      20,850,438        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.23      $ (0.12 )     $ (0.12 ) 
 
    
For The Nine Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (1,372,544 )     $ (39,386 )     $ (198,919 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      2,078,237        —          —    
  
 
 
     
 
 
     
 
 
  
 
    
For The Nine Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Allocation of net income
 
(loss) and deemed dividend
    $ 705,693      $ (39,386 )     $ (198,919 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      34,500,000        990,000        5,000,000  
Basic and diluted net income
 
(loss) per share
    $ 0.02      $ (0.04 )     $ (0.04 ) 
 
    
For The Three
Months Ended
September 30, 2023
     
For The Three
Months Ended
September 30, 2022
  
Net income (loss)
    $ (255,386 )     $ 663,959  
Accretion of temporary equity in excess of fair value
      (128,016 )       (1,560,060 ) 
  
 
 
     
 
 
  
Net loss including accretion of temporary equity in excess of fair value
    $ (383,402 )     $ (896,101 ) 
  
 
 
     
 
 
  
 
    
For The Three Months Ended September 30, 2023
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (51,500 )     $ (54,855 )     $ (277,046 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      128,016        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 76,516      $ (54,855 )     $ (277,046 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      929,456        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.08      $ (0.06 )     $ (0.06 ) 
 
    
For The Three Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (763,534 )     $ (21,910 )     $ (110,657 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      1,560,060        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 796,526      $ (21,910 )     $ (110,657 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      34,500,000        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.02      $ (0.02 )     $ (0.02 ) 
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.
v3.23.3
Related Party Transactions
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions
Note 3—Related Party Transactions
Due to Related Party
An affiliate of the Sponsor paid certain operating costs on behalf of the Company. These advances are due on demand and
non-interest
bearing. During the nine months ended September 30, 2023 and 2022, the related party paid $1,432,646 and $462,062 of
 
operating costs on behalf of the Company, respectively. During the three months ended September 30, 2023 and 2022, the related party paid $0 and $52,648 of operating costs on behalf of the Company, respectively. As of September 30, 2023 and December 31, 2022, the amount due to the related party was $2,591,195 and $1,158,549, respectively.
Founder Shares
On January 19, 2021, the Sponsor acquired 10,000,000 Founder Shares (the “Founder Shares”) for an aggregate purchase price of $25,000, consisting of 5,000,000 Class B Founder Shares (also known as “Class B common stock”) and 5,000,000 Class K Founder Shares (also known as “Class K common stock”). Prior to the initial investment in the Company of $25,000 by the Sponsor, the Company had no assets, tangible or intangible. The per share purchase price of the Founder Shares was determined by dividing the amount of cash contributed to the Company by the aggregate number of Founder Shares issued. On February 28, 2021, the Sponsor entered into a security assignment agreement with six of the Company’s independent directors and assigned 240,000 shares of Class B Founder Shares at an aggregate price of $600.
Class B Founder Shares
The Class B Founder Shares will automatically convert into shares of Class A common stock on the first business day following the completion of our initial Business Combination, at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Class B Founder Shares will equal, in the aggregate on an
as-converted
basis, 15% of the sum of (i) the total number of all shares of Class A common stock issued and outstanding upon completion of this offering (including any over-allotment shares if the underwriters exercise their overallotment option), plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion of the Class B Founder Shares plus (iii) unless waived, the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding (x) any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, deemed issued, or to be issued, to any seller in the initial Business Combination, (y) any shares of Class A common stock issuable upon conversion of the Class K Founder Shares and (z) any Private Placement Shares. Prior to our initial Business Combination, only holders of shares of our Class B common stock will be entitled to vote on the appointment of directors.
Class K Founder Shares
The Class K Founder Shares will convert into shares of Class A common stock after the initial Business Combination only to the extent certain triggering events occur prior to the 10th anniversary of the initial Business Combination, including three equal triggering events based on our stock trading at $30.00, $40.00 and $50.00 per share following the first anniversary of the closing of our initial Business Combination and also upon specified strategic transactions, in each case, as described in this prospectus. The Class K Founder Shares will be convertible into shares of Class A common stock at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares (including both Class B Founder Shares and Class K Founder Shares) will equal, in the aggregate on an
as-converted
basis, 30% of the sum of (i) the total number of all shares of Class A common stock issued and outstanding upon completion of this offering (including any over-allotment shares if the underwriters exercise their overallotment option), plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion of the Class B Founder Shares and Class K Founder Shares plus (iii) unless waived, the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding (x) any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, deemed issued, or to be issued, to any seller in the initial Business Combination and (y) any Private Placement Shares. Prior to our initial Business Combination, only holders of shares of our Class B common stock were entitled to vote on the appointment of directors.
The Company accounts for the Class K Founder Shares as equity linked instruments. Based on the guidance in ASC Topic 815, certain adjustments to the settlement amount of the Class K Founder Shares are based on a variable that is not an input to the fair value of a
“fixed-for-fixed”
option as defined under ASC Topic
815-40
“Derivatives and Hedging”. The Class K Founder Shares are recorded as liabilities as these shares are not considered indexed to the Company’s own stock and not eligible for an exception from derivative accounting.
Working Capital Loans
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans
 
out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.
Private Placement Shares
Simultaneously with the closing of the IPO, the Sponsor has purchased 990,000 Class A common stock at a price of $10.00 per share in a private placement for an aggregate purchase price of $9,900,000. The Private Placement Shares are identical to the shares of Class A common stock shares sold in this offering, subject to certain limited exceptions. The Private Placement Shares holders do not have the option to redeem their Class A common stock and as a result, the proceeds received in connection with the IPO are excluded from temporary equity. The par value of these shares and related additional paid in capital are classified as permanent equity in the Company’s financial statements.
The Initial Stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares until 30 days after the completion of the initial Business Combination.
Forward Purchase Agreement
The Company has entered into a forward-purchase agreement pursuant to which the Sponsor agreed to purchase an aggregate of up to 2,500,000 shares of our Class A common stock (the “forward-purchase shares”) for $10.00 per share, or an aggregate maximum amount of $25,000,000, in a private placement that would close simultaneously with the closing of the initial Business Combination. The proceeds from the sale of these forward- purchase shares, together with the amounts available to the Company from the Trust Account (after giving effect to any redemptions of public shares) and any other equity or debt financing obtained by the Company in connection with the Business Combination, will be used to satisfy the cash requirements of the Business Combination, including funding the purchase price and paying expenses and retaining specified amounts to be used by the post-Business Combination company for working capital or other purposes. To the extent that the amounts available from the Trust Account and other financing are sufficient for such cash requirements, the Sponsor (together with any permitted transferees under the forward-purchase agreement) may purchase less than 2,500,000 forward-purchase shares. The forward-purchase shares would be identical to the public shares being sold in this offering, except the forward-purchase shares would be subject to transfer restrictions and certain registration rights, as described herein. The Company performed an assessment in accordance with ASC Topic 480, and ASC Topic 815 to conclude whether the forward-purchase shares constitute a liability and a derivative such that it will be fair valued separately from the Company’s common stock. The Company concludes that the forward-purchase shares should be equity-classified and its embedded features should not be bifurcated.
v3.23.3
Commitments & Contingencies
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments & Contingencies
Note 4—Commitments & Contingencies
Registration Rights
The holders of the Founder Shares and Private Placement Shares are entitled to registration rights pursuant to the registration agreement signed prior to the consummation of the IPO. The holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statements to become effective until termination of the applicable
lock-up
period.
Underwriting Agreement
The Company granted the underwriters an option to cover over-allotments and for market stabilization purposes. The over-allotment option entitled the underwriters to purchase on a pro rata basis up to 4,500,000 additional Public Shares at the IPO price, less the underwriting fees payable. On March 8, 2021, the Company’s underwriters exercised in full their option to purchase additional Public Shares in connection with the IPO. The underwriters exercised their option to purchase 4,500,000 Public Shares from the Company at a price of $10.00 per share less the underwriting fees payable. This transaction settled on March 8, 2021.
On September 21, 2022, the Company received an executed deferred underwriting fees waiver letter from Goldman Sachs & Co. LLC, informing the Company of its decision to waive any entitlement it may have to its deferred underwriting fees payable held in the Trust Account in respect of any Business Combination. The waiver does not cover deferred underwriting fees payable to Piper Sandler & Co. (representing 10% of the total deferred underwriting fees payable).
v3.23.3
Stockholders' Deficit
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Stockholders' Deficit
Note 5—Stockholders’ Deficit
Preferred Stock—The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.
Class A Common Stock—The Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of September 30, 2023 and December 31, 2022, there were 990,000 shares of Class A common stock issued and outstanding, excluding 929,456 and 34,500,000 shares of common stock subject to possible redemption at September 30, 2023 and December 31, 2022, respectively.
Class B Common Stock—The Company is authorized to issue 30,000,000 shares of Class B common stock with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022 there were 5,000,000 shares of Class B common stock issued and outstanding.
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the stockholders except as required by law.
v3.23.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Note 6—Fair Value Measurements
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023 including the fair value hierarchy of the valuation inputs that the Company utilized to determine such fair value.
 
    
Level 1
     
Level 2
     
Level 3
     
Total
  
Assets
            
Marketable securities held in Trust Account
    $ 10,005,563      $ —      $ —      $ 10,005,563  
Liabilities:
            
Class K Founder Shares derivative liabilities
    $ —      $ —      $ —      $ —  
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022 including the fair value hierarchy of the valuation inputs that the Company utilized to determine such fair value.
 
    
Level 1
     
Level 2
     
Level 3
     
Total
  
Assets
            
Marketable securities held in Trust Account
    $ 350,073,997      $ —      $ —      $ 350,073,997  
Liabilities:
            
Class K Founder Shares derivative liabilities
    $ —      $ —      $ —      $ —  
Class K Founder Shares Derivative Liabilities
Class K Founder Shares is accounted for as liabilities in accordance with ASC Topic 815 and presented as derivative liabilities on the accompanying September 30, 2023 and December 31, 2022 balance sheets. The derivative liabilities were measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of derivative liabilities in the statements of operations. In order to capture the market conditions associated with the Class K Founder Shares derivative liabilities, the Company applied an approach that incorporated a Monte Carlo simulation, which involved random iterations of future stock-price paths over the contractual life of the Class K Founder Shares. Based on assumptions regarding potential changes in control of the Company, and the probability distribution of outcomes, the payoff to the holder was determined based on the achievement of the various market thresholds within each simulated path. The present value of the payoff in each simulated trial is calculated, and the fair value of the liabilities is determined by taking the average of all present values.
The Company believes the Class K Founder Shares have not materially changed since prior quarter. As such, no valuation is performed as of September 30, 2023 and the Company concluded that the liabilities related to the Class K Founder Shares is zero.
The key inputs into the Monte-Carlo simulation model for the Class K Founder Shares derivative liabilities were as follows as of December 31, 2022.
 
Input
   
December 31, 2022
  
Risk-free interest rate
      3.90 % 
Term to business combination
      0.6 years  
Expected volatility
      de minimis  
Stock price
    $ 9.98  
Dividend yield
      0.00 % 
As of September 30, 2023, the fair value of the Class K Founder S
hares
derivative liabilities, a Level 3 liability, remains $0. In addition, there were no transfers to and from Levels 1, 2, and 3 for the three and nine months ended September 30, 2023.
There were no transfers to and from Levels 1, 2, and 3 for the three and nine months ended September 30, 2022.
v3.23.3
Income Taxes
 9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes
Note 7—Income Taxes
The Company’s taxable income primarily consists of interest income on the Trust Account, less any franchise taxes. The Company’s formation costs are generally considered
start-up
costs and are not currently deductible.
The Company recorded an income tax provision of $1,494,132 and $366,506 for the nine months ended September 30, 2023 and 2022, respectively. The effective income tax rate were 27.26% and 43.95% for the nine months ended September 30, 2023 and 2022, respectively. The 27.26% effective income tax rate differs from the federal statutory rate of 21% due to the impact of nondeductible expenses and valuation allowances on deferre
d tax ass
ets. As of September 30, 2023 and December 31, 2022, the Company had $0 of U.S. federal and state net operating loss carryovers available to offset future taxable income, respectively.
In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of deferred tax assets and therefore established a full valuation allowance of $1,900,423 and $1,388,159 as of September 30, 2023, and 2022, respectively.
The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. There were no unrecognized tax benefits as of September 30, 2023 and December 31, 2022. No amounts were accrued for the payment of interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
v3.23.3
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for the period presented.
The interim results for the period ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such an election to opt out
 
is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents and Restricted Cash
The Company considers all short-term investments with a
n original ma
turity of three months or less when purchased to be cash equivalents. The Company had $1,914,188 total in cash but no cash equivalents as of September 30, 2023. Out of the total cash balance, $1,664,188 is classified as restricted cash as those funds will be used for estimated income and franchise tax payments. Withdrawals from the Trust Account are legally restricted for the redemption of common stock, payment of taxes, and payment of expenses in connection with liquidation. This restricted cash is not available to the Company for working capital purposes. The Company had no cash or cash equivalents as of December 31, 2022.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported on the condensed balance sheets that total to the amounts shown on the condensed statements of cash flows.
 
    
September 30, 2023
     
December 31, 2022
  
Cash and cash equivalents
    $ 250,000      $ —    
Restricted cash for income and franchise tax payments
      1,664,188        —    
    
 
 
     
 
 
  
Total cash and cash equivalents and restricted cash
    $ 1,914,188      $ —    
    
 
 
     
 
 
  
Marketable Securities Held in Trust Account
Marketable Securities Held in Trust Account
The Company’s portfolio of investments held in the Trust Account are comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities, dividends and interest held in the Trust Account in the accompanying statements of operations. The fair value for trading securities is determined using quoted market prices in active markets. For the nine months ended September 30, 2023, $
343,677,676
and $
3,533,249
have
been withdrawn from the Trust Account for Class A common stock redemptions as well as tax payments respectively.
Common Stock Subject to Possible Redemption
Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance
in
ASC Topic 480.
Conditionally redeemable common stock (including
common
stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption are classified as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.
The Class A common stock subject to possible redemption are subject to the subsequent measurement guidance in ASC Topic
480-10-S99
“Distinguishing Liabilities from Equity”. Under such guidance, the Company must subsequently measure the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying amount of the common stock is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the common stock subject to possible redemption to their redemption amount (i.e., $10.00 per share) immediately as if the end of the first reporting period after the IPO, March 8, 2021, was the redemption date. Such changes are reflected in additional
paid-in
capital, or in the absence of additional
paid-in
capital, in accumulated deficit. For the three and nine months ended September 30, 2023, the Company recorded an accretion of $128,016 and $7,142,491, respectively, all of which was recorded in accumulated deficit. For the three and nine months ended September 30, 2022, the Company recorded an accretion of $1,560,060 and $2,078,237, respectively, all of which was recorded in accumulated deficit. The Company withdrew $0 and $3,533,249 for the three and nine months ended September 30, 2023, from the Trust Account to pay income and franchise taxes. This was recorded against accumulated deficit. No such income and franchise tax withdrawals occurred from the Trust Account for the three and nine months ended September 30, 2022.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage. As of September 30, 2023 and December 31, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Derivative Financial Instruments
Derivative Financial Instruments
The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period.
Fair Value Measurements
Fair Value Measurements
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets.
The fair value hierarchy is categorized into three levels based on the inputs as follows:
 
  •  
Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
 
  •  
Level 2: Observable inputs other than Level 1 inputs. Example of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
 
  •  
Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The fair value of the Company’s financial assets and liabilities, approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Income Taxes
Income Taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be
more-likely-than-not
to be sustained upon examination by taxing authorities. The Company’s management determined that the United States is the Company’s only major tax jurisdiction.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Net Income (Loss) Per Share of Common Stock
Net Income (Loss) Per Share of Common Stock
Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock outstanding during the period, excluding common stock shares subject to forfeiture.
Class K common stock will convert into Class A common stock after the initial Business Combination only to the extent certain triggering events occur prior to the 10th anniversary of the initial Business Combination, including three equal triggering events based on the Company’s stock trading at $30.00, $40.00 and $50.00 per share following the first anniversary of the closing of the initial Business Combination and also upon specified strategic transactions. The Company has not considered the effect of the Class K common stock in the calculation of diluted net income (loss) per share since the conversion of Class K common stock into Class A common stock is contingent upon the occurrence of future events.
Class B Founder Shares and Private Placement Shares are included in the calculation of
non-redeemable
net loss per share.
The Company’s statements of operations include a presentation of loss per share for shares of common stock subject to possible redemption in a manner similar to the
two-class
method of loss per share. With respect to the accretion of the Class A common stock subject to possible redemption and consistent with ASC Topic
480-10-S99-3A,
the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net income (loss) per common stock. As of September 30, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per share is the same as basic loss per share for the periods presented.
A reconciliation of net income (loss) per common stock is as follows:
 
    
For The Nine
Months Ended
September 30, 2023
     
For The Nine
Months Ended
September 30, 2022
  
Net income
    $ 3,987,471      $ 467,388  
Accretion of temporary equity in excess of fair value
      (7,142,491 )       (2,078,237 ) 
  
 
 
     
 
 
  
Net income including accretion of temporary equity in excess of fair value
    $ (3,155,020 )     $ (1,610,849 ) 
  
 
 
     
 
 
  
 
    
For The Nine Months Ended September 30, 2023
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (2,450,912 )     $ (116,372 )     $ (587,736 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      7,142,491        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 4,691,579      $ (116,372 )     $ (587,736 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      20,850,438        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.23      $ (0.12 )     $ (0.12 ) 
 
    
For The Nine Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (1,372,544 )     $ (39,386 )     $ (198,919 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      2,078,237        —          —    
  
 
 
     
 
 
     
 
 
  
 
    
For The Nine Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Allocation of net income
 
(loss) and deemed dividend
    $ 705,693      $ (39,386 )     $ (198,919 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      34,500,000        990,000        5,000,000  
Basic and diluted net income
 
(loss) per share
    $ 0.02      $ (0.04 )     $ (0.04 ) 
 
    
For The Three
Months Ended
September 30, 2023
     
For The Three
Months Ended
September 30, 2022
  
Net income (loss)
    $ (255,386 )     $ 663,959  
Accretion of temporary equity in excess of fair value
      (128,016 )       (1,560,060 ) 
  
 
 
     
 
 
  
Net loss including accretion of temporary equity in excess of fair value
    $ (383,402 )     $ (896,101 ) 
  
 
 
     
 
 
  
 
    
For The Three Months Ended September 30, 2023
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (51,500 )     $ (54,855 )     $ (277,046 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      128,016        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 76,516      $ (54,855 )     $ (277,046 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      929,456        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.08      $ (0.06 )     $ (0.06 ) 
 
    
For The Three Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (763,534 )     $ (21,910 )     $ (110,657 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      1,560,060        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 796,526      $ (21,910 )     $ (110,657 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      34,500,000        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.02      $ (0.02 )     $ (0.02 ) 
Recent Accounting Pronouncements
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.
v3.23.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents, and Restricted Cash
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported on the condensed balance sheets that total to the amounts shown on the condensed statements of cash flows.
 
    
September 30, 2023
     
December 31, 2022
  
Cash and cash equivalents
    $ 250,000      $ —    
Restricted cash for income and franchise tax payments
      1,664,188        —    
    
 
 
     
 
 
  
Total cash and cash equivalents and restricted cash
    $ 1,914,188      $ —    
    
 
 
     
 
 
  
Schedule of Reconciliation of Net Loss Per Common Stock
A reconciliation of net income (loss) per common stock is as follows:
 
    
For The Nine
Months Ended
September 30, 2023
     
For The Nine
Months Ended
September 30, 2022
  
Net income
    $ 3,987,471      $ 467,388  
Accretion of temporary equity in excess of fair value
      (7,142,491 )       (2,078,237 ) 
  
 
 
     
 
 
  
Net income including accretion of temporary equity in excess of fair value
    $ (3,155,020 )     $ (1,610,849 ) 
  
 
 
     
 
 
  
 
    
For The Nine Months Ended September 30, 2023
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (2,450,912 )     $ (116,372 )     $ (587,736 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      7,142,491        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 4,691,579      $ (116,372 )     $ (587,736 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      20,850,438        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.23      $ (0.12 )     $ (0.12 ) 
 
    
For The Nine Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (1,372,544 )     $ (39,386 )     $ (198,919 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      2,078,237        —          —    
  
 
 
     
 
 
     
 
 
  
 
    
For The Nine Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Allocation of net income
 
(loss) and deemed dividend
    $ 705,693      $ (39,386 )     $ (198,919 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      34,500,000        990,000        5,000,000  
Basic and diluted net income
 
(loss) per share
    $ 0.02      $ (0.04 )     $ (0.04 ) 
 
    
For The Three
Months Ended
September 30, 2023
     
For The Three
Months Ended
September 30, 2022
  
Net income (loss)
    $ (255,386 )     $ 663,959  
Accretion of temporary equity in excess of fair value
      (128,016 )       (1,560,060 ) 
  
 
 
     
 
 
  
Net loss including accretion of temporary equity in excess of fair value
    $ (383,402 )     $ (896,101 ) 
  
 
 
     
 
 
  
 
    
For The Three Months Ended September 30, 2023
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (51,500 )     $ (54,855 )     $ (277,046 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      128,016        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 76,516      $ (54,855 )     $ (277,046 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      929,456        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.08      $ (0.06 )     $ (0.06 ) 
 
    
For The Three Months Ended September 30, 2022
  
    
Class A-t (Temporary)
     
Class A-p (Permanent)
     
Class B
  
Basic and diluted net income (loss) per share
         
Numerator
         
Allocation of net loss including accretion of temporary equity in excess of fair value
    $ (763,534 )     $ (21,910 )     $ (110,657 ) 
Deemed dividend for accretion of temporary equity in excess of fair value
      1,560,060        —          —    
  
 
 
     
 
 
     
 
 
  
Allocation of net income (loss) and deemed dividend
    $ 796,526      $ (21,910 )     $ (110,657 ) 
  
 
 
     
 
 
     
 
 
  
Denominator
         
Weighted average shares outstanding, basic and diluted
      34,500,000        990,000        5,000,000  
Basic and diluted net income (loss) per share
    $ 0.02      $ (0.02 )     $ (0.02 ) 
v3.23.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities That Are Measured at Fair Value on Recurring Basis
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023 including the fair value hierarchy of the valuation inputs that the Company utilized to determine such fair value.
 
    
Level 1
     
Level 2
     
Level 3
     
Total
  
Assets
            
Marketable securities held in Trust Account
    $ 10,005,563      $ —      $ —      $ 10,005,563  
Liabilities:
            
Class K Founder Shares derivative liabilities
    $ —      $ —      $ —      $ —  
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022 including the fair value hierarchy of the valuation inputs that the Company utilized to determine such fair value.
 
    
Level 1
     
Level 2
     
Level 3
     
Total
  
Assets
            
Marketable securities held in Trust Account
    $ 350,073,997      $ —      $ —      $ 350,073,997  
Liabilities:
            
Class K Founder Shares derivative liabilities
    $ —      $ —      $ —      $ —  
Summary of Fair Value Measurement Inputs and Valuation Techniques
The key inputs into the Monte-Carlo simulation model for the Class K Founder Shares derivative liabilities were as follows as of December 31, 2022.
 
Input
   
December 31, 2022
  
Risk-free interest rate
      3.90 % 
Term to business combination
      0.6 years  
Expected volatility
      de minimis  
Stock price
    $ 9.98  
Dividend yield
      0.00 % 
v3.23.3
Description of Organization, Business Operations and Going Concern - Additional Information (Detail) - USD ($)
 9 Months Ended
Aug. 18, 2023
Jun. 12, 2023
Sep. 30, 2021
Mar. 08, 2021
Sep. 30, 2023
Dec. 31, 2022
Sep. 21, 2022
Entity incorporation, date of incorporation         Jan. 15, 2021    
Percentage of the net assets of the target company excluding the amount of any deferred underwriting commissions         80.00%    
Interest expense, trust account         $ 100,000    
Liquidation basis of accounting, liquidation plan         if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims    
Cash and cash equivalents         $ 1,914,188    
Working capital deficit         6,181,313    
Interest income         $ 7,142,491    
Underwriter Deferred Discount       $ 12,075,000      
Percentage of Public Shares that would not be redeemed if Business Combination is not completed within Initial Combination Period         100.00%    
Period to complete Business Combination from closing of Initial Public Offering         27 months    
Cash deposited in Trust Account per share     $ 10        
Dissolution Expense         $ 100,000    
Temporary Equity Shares Outstanding         929,456 34,500,000  
Restricted Cash         $ 1,664,188 $ 0  
Minimum Amount Of Market Value Of Listed Securities $ 35,000,000            
Target Company [Member]              
Equity method investment ownership percentage         50.00%    
Piper Sandler Co [Member]              
Percentage of deferred underwriting fees payable         10.00%   10.00%
Maximum [Member]              
Period to complete Business Combination from closing of Initial Public Offering         33 months    
Asset Held In Trust Account [Member]              
Shares issued, price per share         $ 10    
Public Stockholders [Member]              
Net tangible assets         $ 5,000,001    
Percentage of public shareholding eligible for redemption without prior consent         15.00%    
Percentage of public shareholding eligible for redemption on non occurrence of business combination         100.00%    
IPO [Member]              
Stock shares issued during the period shares       345,000,000      
Sale of stock issue price per share       $ 10      
IPO [Member] | Sponsor [Member]              
Stock shares issued during the period shares       300,000,000      
Over-Allotment Option [Member]              
Stock shares issued during the period shares         4,500,000    
Shares issued, price per share       $ 10      
Sale of stock issue price per share       $ 10      
Additional Number Of Shares Purchased       4,500,000 4,500,000    
IPO Including Over Allotment Option [Member]              
Proceeds from issuance initial public offering       $ 34,500,000      
Common Class A [Member]              
Common stock par value per share         $ 0.0001 $ 0.0001  
Stock redeemed or called during period shares   33,570,544          
Temporary equity par share   $ 10.237     $ 0.0001 $ 0.0001  
Temporary Equity Shares Outstanding         929,456 34,500,000  
Common Class A [Member] | IPO [Member]              
Stock shares issued during the period shares       30,000,000      
Common stock par value per share       $ 0.0001      
Common Class A [Member] | Private Placement [Member]              
Stock shares issued during the period shares       990,000      
Common stock par value per share       $ 0.0001      
Shares issued, price per share       $ 10      
Proceeds from issuance of private placement       $ 9,900,000      
Sale of stock issue price per share         $ 10    
v3.23.3
Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Detail) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]    
Cash and cash equivalents $ 250,000 $ 0
Restricted cash for income and franchise tax payments 1,664,188 0
Total cash and cash equivalents and restricted cash $ 1,914,188 $ 0
v3.23.3
Summary of Significant Accounting Policies - Schedule of Reconciliation of Net Loss Per Common Stock (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]                
Net income (loss) $ (255,386) $ 2,097,534 $ 2,145,323 $ 663,959 $ 46,466 $ (243,037) $ 3,987,471 $ 467,388
Accretion of temporary equity in excess of fair value (128,016)     (1,560,060)     (7,142,491) (2,078,237)
Net income (loss) including accretion of temporary equity in excess of fair value (383,402)     (896,101)     (3,155,020) (1,610,849)
Numerator                
Allocation of net income (loss) and deemed dividend (255,386) $ 2,097,534 $ 2,145,323 663,959 $ 46,466 $ (243,037) 3,987,471 467,388
Common Class A [Member] | Common Stock Subject To Possible Redemption [Member]                
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]                
Net income (loss) 76,516     796,526     4,691,579 705,693
Numerator                
Allocation of net loss including accretion of temporary equity in excess of fair value (51,500)     (763,534)     (2,450,912) (1,372,544)
Deemed dividend for accretion of temporary equity in excess of fair value 128,016     1,560,060     7,142,491 2,078,237
Allocation of net income (loss) and deemed dividend $ 76,516     $ 796,526     $ 4,691,579 $ 705,693
Denominator                
Weighted average shares outstanding, basic 929,456     34,500,000     20,850,438 34,500,000
Weighted average shares outstanding, diluted 929,456     34,500,000     20,850,438 34,500,000
Basic net income (loss) per share $ 0.08     $ 0.02     $ 0.23 $ 0.02
Diluted net income (loss) per share $ 0.08     $ 0.02     $ 0.23 $ 0.02
Common Class A [Member] | Common Stock [Member]                
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]                
Net income (loss) $ (54,855)     $ (21,910)     $ (116,372) $ (39,386)
Numerator                
Allocation of net loss including accretion of temporary equity in excess of fair value (54,855)     (21,910)     (116,372) (39,386)
Deemed dividend for accretion of temporary equity in excess of fair value 0     0     0 0
Allocation of net income (loss) and deemed dividend $ (54,855)     $ (21,910)     $ (116,372) $ (39,386)
Denominator                
Weighted average shares outstanding, basic 990,000     990,000     990,000 990,000
Weighted average shares outstanding, diluted 990,000     990,000     990,000 990,000
Basic net income (loss) per share $ (0.06)     $ (0.02)     $ (0.12) $ (0.04)
Diluted net income (loss) per share $ (0.06)     $ (0.02)     $ (0.12) $ (0.04)
Common Class B [Member] | Common Stock [Member]                
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]                
Net income (loss) $ (277,046)     $ (110,657)     $ (587,736) $ (198,919)
Numerator                
Allocation of net loss including accretion of temporary equity in excess of fair value (277,046)     (110,657)     (587,736) (198,919)
Deemed dividend for accretion of temporary equity in excess of fair value 0     0     0 0
Allocation of net income (loss) and deemed dividend $ (277,046)     $ (110,657)     $ (587,736) $ (198,919)
Denominator                
Weighted average shares outstanding, basic 5,000,000     5,000,000     5,000,000 5,000,000
Weighted average shares outstanding, diluted 5,000,000     5,000,000     5,000,000 5,000,000
Basic net income (loss) per share $ (0.06)     $ (0.02)     $ (0.12) $ (0.04)
Diluted net income (loss) per share $ (0.06)     $ (0.02)     $ (0.12) $ (0.04)
v3.23.3
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Restricted cash and cash equivalents $ 1,914,188           $ 1,914,188   $ 0
Shares measured to their redemption amount due to initial carrying amount of the common stock is less price per share $ 10           $ 10    
Temporary Equity, Redemption Price Per Share $ 10           $ 10    
Temporary equity accretion to redemption value $ 128,016 $ 3,271,429 $ 3,743,046 $ 1,560,060 $ 490,019 $ 28,158      
Maturity of investment held in trust account             180 days    
Cash equivalents 0           $ 0    
Restricted cash income and franchise tax payments 1,664,188           1,664,188   $ 0
Trust account withdrawal redemption             343,677,676 $ 0  
Trust account withdrawal tax payment 0     0     3,533,249 0  
Common Class A [Member]                  
Temporary equity accretion to redemption value $ 128,016     $ 1,560,060     $ 7,142,491 $ 2,078,237  
Triggering Events Stock Trading Price One [Member] | Common Class A [Member]                  
Conversion of share, price per share             $ 30    
Triggering Events Stock Trading Price Two [Member] | Common Class A [Member]                  
Conversion of share, price per share             40    
Triggering Events Stock Trading Price Three [Member] | Common Class A [Member]                  
Conversion of share, price per share             $ 50    
v3.23.3
Related Party Transactions - Additional Information (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Feb. 28, 2021
Jan. 19, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Dec. 31, 2022
Due to related party     $ 2,591,195   $ 2,591,195 $ 1,158,549
Operating costs and expenses:     $ 0 $ 52,648    
Other Receivable, after Allowance for Credit Loss, Current, Related Party, Type [Extensible Enumeration]     Related Party [Member]   Related Party [Member]  
Other Liability, Related Party, Type [Extensible Enumeration]       Related Party [Member]    
Private Placement [Member]            
Lock in period of shares         30 days  
Sponser [Member]            
Due to Related Parties       $ 462,062    
Other receivables     $ 1,432,646   $ 1,432,646  
Related Party [Member] | Operating Costs Incurred Related Party [Member]            
Due to related party     $ 2,591,195   $ 2,591,195 $ 1,158,549
Founder shares [Member]            
Stock shares issued during the period for services shares   10,000,000        
Stock shares issued during the period for services value   $ 25,000        
Common Class A [Member] | Triggering Events Stock Trading Price One [Member]            
Conversion of share, price per share         $ 30  
Common Class A [Member] | Triggering Events Stock Trading Price Two [Member]            
Conversion of share, price per share         40  
Common Class A [Member] | Triggering Events Stock Trading Price Three [Member]            
Conversion of share, price per share         $ 50  
Common Class A [Member] | Private Placement [Member]            
Sale of Stock, Number of Shares Issued in Transaction         990,000  
Sale of Stock, Price Per Share     $ 10   $ 10  
Sale of Stock, Consideration Received Per Transaction         $ 9,900,000  
Common Class A [Member] | Forward Purchase Agreement [Member]            
Sale of Stock, Number of Shares Issued in Transaction         2,500,000  
Sale of Stock, Price Per Share     $ 10   $ 10  
Sale of Stock, Consideration Received Per Transaction         $ 25,000,000  
Common Class B [Member]            
Stock shares issued during the period for services shares   5,000,000        
Common Class K [Member]            
Stock shares issued during the period for services shares   5,000,000        
Class B Founder Shares [Member]            
Stock shares issued during the period for services shares 240,000          
Stock shares issued during the period for services value $ 600          
Percent of stock convertible     15.00%   15.00%  
Class K Founder Shares [Member]            
Percent of stock convertible     30.00%   30.00%  
v3.23.3
Commitments & Contingencies - Additional Information (Detail) - $ / shares
 9 Months Ended
Sep. 30, 2023
Sep. 21, 2022
Mar. 08, 2021
Piper Sandler Co [Member]      
Loss Contingencies [Line Items]      
Percentage of deferred underwriting fees payable 10.00% 10.00%  
Over-Allotment Option [Member]      
Loss Contingencies [Line Items]      
Additional number of shares purchased 4,500,000   4,500,000
Sale of Stock, Price Per Share     $ 10
Stock shares issued during the period shares 4,500,000    
v3.23.3
Stockholders' Deficit - Additional Information (Detail) - $ / shares
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Preferred Stock Par Value Per Share $ 0.0001 $ 0.0001
Preferred Stock Shares Authorized 1,000,000 1,000,000
Preferred Stock Shares Issued 0 0
Preferred Stock Shares Outstanding 0 0
Common stock subject to possible redemption 929,456 34,500,000
Common Stock Subject to Mandatory Redemption [Member]    
Common stock subject to possible redemption 34,500,000  
Common Class A [Member]    
Common Stock Par Value Per Share $ 0.0001 $ 0.0001
Common Stock Shares Authorized 200,000,000 200,000,000
Common Stock Shares Issued 990,000 990,000
Common Stock Shares Outstanding 990,000 990,000
Common stock subject to possible redemption 929,456 34,500,000
Common stock shares voting rights one vote  
Common Class B [Member]    
Common Stock Par Value Per Share $ 0.0001 $ 0.0001
Common Stock Shares Authorized 30,000,000 30,000,000
Common Stock Shares Issued 5,000,000 5,000,000
Common Stock Shares Outstanding 5,000,000 5,000,000
v3.23.3
Fair Value Measurements - Summary of Assets and Liabilities That Are Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Marketable securities held in Trust Account [Member]    
Assets:    
Marketable securities held in Trust Account $ 10,005,563 $ 350,073,997
Class K Founder Shares [Member]    
Liabilities:    
Class K Founder Shares derivative liabilities 0 0
Level 1 [Member] | Marketable securities held in Trust Account [Member]    
Assets:    
Marketable securities held in Trust Account 10,005,563 350,073,997
Level 3 [Member] | Class K Founder Shares [Member]    
Liabilities:    
Class K Founder Shares derivative liabilities $ 0 $ 0
v3.23.3
Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) - Class K Founder Shares [Member]
Dec. 31, 2022
yr
Input Risk-free interest rate [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 3.9
Term to Business Combination [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 0.6
Expected volatility [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 0
Stock price [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 9.98
Dividend yield [Member]  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Derivative Liability, Measurement Input 0
v3.23.3
Fair Value Measurements - Additional Information (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Fair Value, Inputs, Level 1, 2 and 3 [Member]          
Fair Value Disclosures [Line Items]          
Transfers between levels $ 0 $ 0 $ 0 $ 0  
Fair Value, Inputs, Level 3 [Member] | Class K Founder Shares Liability [Member]          
Fair Value Disclosures [Line Items]          
Fair value of derivative liabilities $ 0   $ 0   $ 0
v3.23.3
Income Taxes - Additional Information (Detail) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Changes in valuation allowance     $ 1,900,423 $ 1,388,159  
Unrecognized tax benefits $ 0   0   $ 0
Accrued interest and penalties 0   0   0
Income Tax Expense (Benefit) 19,907 $ 317,113 $ 1,494,132 $ 366,506  
Effective Income Tax RatReconciliation, Percent     27.26% 43.95%  
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent     21.00%    
Domestic Tax Authority [Member]          
Operating loss carryforwards $ 0   $ 0   $ 0
Khosla Ventures Acquisit... (NASDAQ:KVSA)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024 Haga Click aquí para más Gráficas Khosla Ventures Acquisit....
Khosla Ventures Acquisit... (NASDAQ:KVSA)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024 Haga Click aquí para más Gráficas Khosla Ventures Acquisit....